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Abstract
Mammalian cells are dynamical systems. They detect, adapt and respond
to time-varying inputs such as environmental cues, secreted molecules, and
mechanical stimuli. These processes are controlled by networks of genes,
proteins, small molecules, and their mutual interactions, the so-called gene
regulatory networks, showing complex topologies. Understanding how these
networks work is essential to identify triggering events both in common
disease as well as in rare genetic disorders.
Control Theory makes available several tools that can be applied to ex-
plore the mechanisms driving gene networks.
Although recently several successful attempts to apply the Control The-
ory to steer gene expression from inducible promoters have been obtained
in lesser eukaryotes, the application of control engineering to mammalian
cells is still in its infancy because of complexity and the limited knowledge
of their transcriptional networks.
This Thesis is involved in this challenging topic. I propose the study
and the in vitro implementation of feedback control strategies based on
microfluidic platform aimed to precisely regulate the level of expression of a
protein from the tetracycline inducible promoter in mammalian cells. This
control approach allows to express a protein of interest at different levels
or in a time-varying fashion from the same promoter and can be a unique
tool for several applications, including studying the effects of gene dosage
in disease, probing the function of endogenous regulatory networks, and for
synthetic biology applications.
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CHAPTER 1
Introduction
1.1 Background and motivation
Mammalian cells are dynamical systems. They detect, adapt and respond
to time-varying inputs such as environmental cues, secreted molecules, and
mechanical stimuli. These processes are controlled by networks of genes,
proteins, small molecules, and their mutual interactions, the so-called gene
regulatory networks, showing complex topologies. Understanding how these
networks work is essential to identify triggering events both in common
disease as well as in rare genetic disorders.
Control Theory makes available several tools that can be apllied to ex-
plore the mechanisms driving gene networks [1, 2]. The application of Con-
trol Theory to biological systems has a long history. In 50-60s, researchers
started to describe a biological function, i.e. the regulation of CO2 by the
respiratory system, in terms of a feedback-control system by drawing an
analogy to an electric circuit [3, 4, 5, 6]. However, the study of molecular
biology from a control theory perspective has been mostly theoretical for
the last 60 years, mainly because of a lack of quantitative measurements
of molecular processes. The advent of new technologies to quantitatively
measure molecular species and manipulate cells has now enabled practical
applications of control engineering to living systems.
1
2Recently, several successful attempts to apply the Control Theory to
steer gene expression from inducible promoters have been reported in the
literature, but only in lesser eukaryotes [7, 8, 9, 10, 11, 12].
Indeed transcriptional networks in mammalian cells are very complex and
their knowledge is very limited. A typical mammalian cell can express more
than 104 genes at any given time, which are regulated by tens or hundreds
of different transcription factors. For these reasons, the transcription in
mammalian cells is up to 1 order of magnitude slower than in bacteria or
simple eukaryotes, therefore, the time scale involved in the control of gene is
expression is much longer [13]. Moreover, mammalian cells have much more
stringent requirements for in vitro experiments. For all these reasons the
application of control engineering to mammalian cells is still in its infancy.
My Thesis is involved in this challenging topic. I propose the study
and the in vitro implementation of feedback control strategies based on
microfluidic platform aimed to precisely regulate the level of expression of a
protein from the tetracycline inducible promoter in mammalian cells. This
control approach allows to express a protein of interest at different levels
or in a time-varying fashion from the same promoter and can be a unique
tool for several applications, including studying the effects of gene dosage
in disease, probing the function of endogenous regulatory networks, and for
synthetic biology applications.
1.2 Thesis outline
In Chapter 2 I give an overview of the application of Control Theory in
Molecular Biology introducing some biological concepts, such as gene ex-
pression and inducible promoter, and I present the negative feedback control
strategies used in this work.
In Chapter 3 I provide details of the experimental platform used for con-
trolling of gene expression in a population of mammalian cells.
3In Chapter 4 I propose the design and the in vitro implementation of Re-
lay and Proportional-Integral control strategies to regulate in real-time gene
expression from endogenous promoters by providing a discrete control input.
In Chapter 5 I describe the construction of an tetracycline inducible syn-
thetic gene network exhibiting fast dynamics. I discuss the use of the ex-
perimental platform presented in Chapter 3 to infer quantitative dynamical
models of transcriptional processes from measured input and output data.
Moreover I present a Model Predictive Control strategy to regulate the gene
expression of this tetracycline inducible system with a discrete control input.
In Chapter 6 I propose the implementation of an active control strategy for
regulating tetracycline concentration (or any other small molecule) within a
microfluidic device.
In Chapter 7 I present the implementation of Model Predictive Control
strategy for gene expression with a continuous actuation by enabling any
desired tetracycline concentration to be provided to the cells in the mi-
crofluidic device. I present the preliminary experimental results of the in
vitro set point control experiment.
All this study has been completed in the Systems and Synthetic Biology
Laboratory at TIGEM under the supervision of Dr. Diego di Bernardo
(Principal Investigator). The experimental platform showed in Chapter 3
was implemented by Dr. Filippo Menolascina (Institute for Bioengineering,
School of Engineering, The University of Edinburgh, Scotland, UK) and
Dr. Gianfranco Fiore (Department of Engineering Mathematics, University
of Bristol, UK) to control gene expression in yeast cell. In collaboration
with Dr. Chiara Fracassi (LIFEWARE group INRIA, Palaiseau, France),
I adapted the set-up for mammalian cells and I perform the pilot study to
assess the feasibility of controlling gene expression from inducible promoter
4in mammalian cells described in Chapter 4. The data and the discussion
presented in Chapters 5, 6 and 7 have been generated by my own work.
CHAPTER 2
Molecular Biology and Control
Theory
In this Chapter, I first introduce biological concepts such as gene expression
and inducible system. I then propose a brief overview of current advances in
the application of Control Theory to biological systems. Finally, I present
the negative feedback control strategies that I implemented in my PhD work
to control gene expression in mammalian cells.
2.1 Gene expression and inducible promoter
In living cells, the complex process by which genetic information gets ul-
timately transformed into working proteins is called gene expression. The
main steps of gene expression are: a) the synthesis of RNA from a DNA
template known as transcription and b) the protein synthesis from an RNA
template known as translation; several intermediate editing steps usually
take place as well. The sequences of the DNA that encode instructions
for proteins’ production are called genes. In the transcription process the
enzyme RNA polymerase (RNAp) binds a defined site at the promoter, a
regulatory region of DNA that precedes the gene, and produces mRNA that
corresponds to gene’s coding sequence. The mRNA is then translated into
a protein [14]. A scheme of gene expression process is shown in Figure 2-1.
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Figure 2-1: Scheme of gene expression process. The main steps of gene
expression are the transcritpion and tranlation processes. Transcription of a
gene is the process by which RNAp (RNA polymerase) produces the mRNA
corresponding to the gene coding sequence by binding a specific site of the
promoter. The mRNA is then translated into a protein. Adopted from [15].
Gene expression however is a complex process regulated at several stages
in the synthesis of proteins. Some proteins are structural and will accumulate
at the cell-wall or within the cell to give it particular properties. Other
proteins can be enzymes that catalyze certain reactions. A large group of
proteins have an important role in the regulation of the genes, these are
known as transcription factors [15].
Gene regulation by transcription factors can be negative or positive. In
negative regulation, an inhibitor protein binds to the promoter and decreases
the mRNA transcription of the gene. In positive regulation, a transcription
factor is required to bind at the promoter in order to increase the mRNA
transcription rate. Transcription factor proteins are themselves encoded by
the genes, which are regulated by other transcription factors regulated yet
7by other transcription factors, and so on. This set of interactions form a
transcriptional network describing all of the regulatory transcriptional in-
teraction in the cell [15].
The network, actually the cell, is a dynamical system: following an in-
put signal (i.e. a molecule, a post-translational modification, a change in
the physical properties of the environment), transcription factor activities
change causing the variation in the production rate of proteins. The abil-
ity to apply precise inputs to the transcriptionals network in living cells is
essential for interrogating and understanding complex cell signaling systems
[16].
In molecular biology, the most common approach to induce a perturba-
tion in the expression of a transcription factor in mammalian cells is the
use of inducible promoters responding to small molecule. Typically, a small
molecule is added to (or removed from) the cell growing medium and the
expression of the transcription factor is induced.
The tetracycline-responsive promoter developed by Bujard and collegues
in [17, 18] is a paradigm of this class of inducible systems.
The first critical feature of the tet-system is the regulatory protein. For
example, in the Tet-OFF system shown in Figure 2-2, the regulatory pro-
tein is the tetracycline-transactivator (tTA) protein. The tTa is a synthetic
transcription factor created by fusing TetR with the C-terminal domain of
VP16 [18]. The second critical component is the response plasmid which
expresses a gene of interest under control of the CMVTET promoter which
consists of seven tet-responsive operator motifs (tetO7 ) located just up-
stream of the minimal CMV promoter (PminCMV ). In the Tet-OFF system,
tTA protein is able to bind the CMVTET thus driving the expression of the
downstream gene of interest (e.g. the transcription factor to be perturbed)
in absence of tetracycline (or doxycycline). Upon addition of tetracycline (or
doxycycline), tTA is no longer able to bind the CMVTET promoter, thus
preventing downstream gene expression (Figure 2-2). Several variations of
this inducible system exist, but all are based on the same principle [19].
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Figure 2-2: Scheme of gene regulation in the Tet-Off system.
The tetO7 element is located upstream of the minimal CMV promoter
(PminCMV ). tTA binds the tetO7 and thereby activates transcription of
gene of interest in the absence of tetracycline (or doxycycline). In presence
of tetracycline, tTa is not able to bind the CMVTET promoter preventing
the downstream gene expression. From https://www.clontech.com/
9The limitation of these systems is that the downstream gene can be either
fully expressed or repressed and it is very difficult to achieve intermediate
expression levels by dosing the small molecule concentration, because of the
highly nonlinear dose-response curve of the promoter. Hence, inducible pro-
moters only allow "binary" expression levels. Moreover, there is no control
on the expression dynamics. However, by applying feedback control strate-
gies these limitations may be overcome and the expression level from the
inducible promoter varied at will in a desired manner.
2.2 Approaches to control gene expression
In the last years, successful attempts to control gene expression in bacteria
and yeast have been described in the literature. They mainly differ in the
control input, the control strategy adopted and in the actuation strategies
that are mainly based on optogenetics and microfluidics.
In 2011, Milias-Argeitis et al. exploited an optogenetics-based light in-
ducible system to control gene expression from the GAL1 promoter in yeast
cells [8]. By using light stimuli as control input, they developed an Model
Predictive Control (MPC) strategy to achieve set-point regulation of the
mean fluorescence of a reporter protein over the entire cell population mea-
sured via flow cytometry.
In 2014, Olson and collegues developed an optogenetic based method
for programming tailor-made gene expression signals in live bacterial cells
[20]. They designed an open-loop control algorithm that uses the dynamical
models of light-switchable two-component systems to simulate the gene ex-
pression response and interatively optimizes the light control program until
the error between the reference and the simulation is sufficiently small.
More recently, Milias-Argenteis and collegues presented a completely au-
tomatic experimental platform for the robust and precise long-term opti-
cal feedback control of gene expression driven by a light-switchable two-
component system in liquid bacterial cultures [12]. They demonstrated the
10
ability of the optogenetic platform to satisfy set-point and tracking objec-
tives when controlling gene expression with Proportional-Integral (PI) or
MPC controllers and they performed a comparative analysis of this two
control strategies.
On the other hand, microfluidic devices, allowing a tight control of cel-
lular environment and the administration of inducer small-molecules, have
been successfully exploited by Uhlendorf et al. to control the expression of
a reporter protein from the Hog1-responsive promoter in yeast cells by us-
ing changes in osmotic pressure as control input [9]. Authors demonstrated
that a Model Predictive Control strategy was effective in achieving for both
time-constant and time-varying amount of fluorescence at the population
and even the single-cell levels.
A completely automated microfluidic platform was developed to suc-
cessful control in real-time gene expression in yeast cells from the GAL1
inducible promoter as descibed in [21, 10, 11]. The authors demonstrated
the ability of the platform to satisfy set-point and tracking objectives when
controlling gene expression either with PI or MPC controllers, where the
control inputs were galactose and glucose, while the output was the average
fluorescence level of a reporter protein downstream of the GAL1 promoter
across yeast cells.
Although control of gene expression in lesser eukaryotes has been success-
ful achieved, the application of control engineering to mammalian systems
is still in its infancy. The transcriptional dynamics of mammalian cells are
slower than bacteria or yeast and therefore the time scale involved in the
control of gene expression is much longer; moreover mammalian cells have
much more stringent requirements for culture conditions. These constraints
have hindered the application of automatic control to mammalian systems.
A pioneering work in mammalian cells was performed in 2011 by Toettcher
and collegues who described an optogenetic approach to control the post-
translational activation of the PI3K cascade, with a PI controller through
automatic adjustment of the light input to single cells [16].
11
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Figure 2-3: Relay controller. Relay controller’s characteristics with feed-
back error e on the x axis and the control input u on the y axis. The ideal
controller is depicted in A while a version with hysteresis is shown in B.
However building on the results achieved in yeast cells by microfluidics
[21, 10, 11], I decided to control gene expression from the tetracycline in-
ducible promoter in mammalian cells with a microfluidics-based control
strategy.
Next sections deal with the explanation of the control strategies I de-
signed and implemented during my PhD work.
2.2.1 Relay
This simple control strategy can be expressed as follows:
u(t) =
{
umax if e(t) > 0
umin if e(t) < 0
(2-1)
where the control error e(t) = r(t)− y(t) is the difference between the refer-
ence signal r and the system output y. u is the control input. This control
strategy, although being simple, succeeds in keeping the system output close
to the desired reference. Typically the controlled variable oscillates around
the reference and it is acceptable if the oscillation is sufficiently small [22].
In addition, when the output value is very close to the reference, the control
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error can rapidly change sign, thus causing the control input to continuously
switch (chattering phenomenon [23]). To reduce the chattering, which can
increase in presence of measurement noise, hysteresis  can be added to the
controller modifying the control law as follows:
u(t) =
{
umax if e(t) ≥ 
umin if e(t) < −
(2-2)
Thus in the Relay with hysteresis, the output depends on the value of past
inputs. The drawback of this controller is that the amplitude of the oscil-
lations around the set-point increases. The relation between error e and
control input u is shown in Figure 2-3 for both relay controller and relay
with hysteresis.
2.2.2 PID Control
Proportional-Integral-Derivative (PID) control is by far the most common
controller in industry. Moreover there are also evidence that PID control is
encoded in biological systems [24]. PID controllers appear in many different
forms: as stand-alone controllers, as part of hierarchical, distributed con-
trol systems and built into embedded components. Block diagrams of PID
controller is shown in Figure 2-4.
The control action for a PID controller is described as:
u(t) = kpe(t) + ki
∫ t
0
e(τ)dτ + kd
de(t)
dt
(2-3)
where u is the control input and e = r − y is the control error. y is the
measured process variable and r is the reference. The control action is thus
a sum of three terms: the proportional term which is proportional to the
error, the integral term which is proportional to the integral of the error,
and the derivative term which is proportional to the derivative of the error.
The controller parameters are the proportional gain kp, the integral gain ki
and the derivative gain kd. The integral, proportional and derivative term
can be interpreted as control actions based on the past, the present and the
future represented by a linear extrapolation of the error (Figure 2-5).
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Figure 2-4: Block diagram of PID controller. The controller has one
output y, the control signal is u. For this controller, proportional, integral
and derivative action acts on the control error e = r − y.
The action of the different terms can be illustrated by considering the
response of the system output to a unit step as reference. As shown in
Figure 2-6 A, by considering pure proportional control the output never
reaches the reference and thus a non zero steady state error is present. The
error decreases with increasing proportional gain kp, but the system tendency
towards oscillation increases. Figure 2-6 B illustrates how the zero steady
state error is achieved when the integral term is added to the control action.
With integral action the rise time is increased. The system is speeded up by
increasing the integral gain ki, but the closed loop system is likely to escape
the stability region. Finally, Figure 2-6 C illustrates the effect of derivative
action: the system is oscillatory when no derivative action is used, and
it becomes more damped as the derivative gain is increased. Performance
deteriorates if the derivative gain is too high. The derivative term not does
14
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Figure 2-5: Action of a PID controller. At time t, the proportional term
kpe(t) depends on the instantaneous value of the error. The integral portion
of the feedback ki
∫ t
0
e(τ)dτ is based on the integral of the error up to time
t (shaded portion). The derivative term kd de(t)dt provides an estimate of the
growth or decay of the error over time by looking at the rate of change of
the error. Adapted from [22].
not have any effect on the steady state error.
In the majority of practical applications of PID control, the derivative
action is not used because of its variable impact on system stability in real-
world applications and also because in the presence of noisy measurements
as the control action would become noisy due to the high pass filter nature
of the derivative term [25].
Integrator Windup In practical applications, the control action is fed
to the plant by the actuator system that tipically has limitations (a motor
has limited speed, a valve cannot be more than fully opened or fully closed,
etc). For a control system with a wide range of operating conditions, it
may happen that the control action reaches the actuator limits. When this
happens the feedback loop is broken and the system runs as an open loop
because the actuator will remain at its limit independently of the process
output. If a controller with integral action is used, the error will continue
to be integrated meaning that the integral term and the control output may
become very large. The control signal will then remain saturated even when
the error changes, and it may take a long time before the integrator and
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Figure 2-6: Effect of the gains of PID controller gain. Responses to
step changes in the reference value for a system with a proportional controller
(A), PI controller (B) and PID controller (C). Adapted from [22].
the controller output come inside the saturation range. This phenomenon is
called integrator windup [22].
To avoid the effects due of windup, a possible solution is to modify the
PI scheme as shown in Figure 2-7 (see also [22]). The system has an extra
feedback path that is generated by measuring the actual actuator output u
and computing an error signal es as the difference between the the actuator
output u and output of the controller uˆ . The signal es is added to the
integrator input trough kt. The signal es is zero when there is no saturation
and thus it not has any effect on the normal operation when the actuator
does not saturate. When the actuator saturates, the signal es is fed back
to the integrator implying that that controller output uˆ is kept close to the
saturation limit. The controller output will then change as soon as the error
changes sign and integral windup is avoided.
PI control with the anti-windup scheme shown in Figure 2-7 will be used
in this Thesis to control gene expression of CHO tetO7 -d2EYFP cells (see
Chapter 4)
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Figure 2-7: Block diagram of PID controller with anti-windup. The
input to the integrator consists of the error term e plus a "reset" es based on
input saturation. If the actuator is not saturated, then es = uuˆ, otherwise
es will decrease the integrator input to prevent windup.
The first advantage of PI controller is that, besides its very simple im-
plementation, it guarantee zero steady-state error for constant reference and
the rejection of constant disturbances at steady-state. Moreover, the PI
controller does not require a model of the controlled system, although an
idea of its dynamics is necessary for gains’ tuning. On the other hand, a
PI controller does not achieve a satisfactory performance for tracking time-
varying references unless the reference dynamics are much slower than the
closed-loop system dynamics.
These limitation can be addressed by an MPC controller even if the
improved performance has a computational cost, since MPC is more complex
than PI control [26].
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2.2.3 Model Predictive Control
Model Predictive Control (MPC) is a well-established technique for control-
ling multivariable systems subject to constraints on manipulated variables
and outputs in an optimized way. Following a long history of success in the
process industries, in recent years MPC is rapidly expanding in several other
domains, such as in the automotive and aerospace industries, smart energy
grids, and financial engineering [27, 28, 29, 30].
In recent years, the MPC approach has been also used to control biolog-
ical process [8, 12, 9, 11].
The conceptual structure of MPC is depicted in Figures 2-8 and 2-9 .
The MPC arises from the idea of employing an explicit model of the plant
to be controlled which is used to predict the future output behavior.
Specifically, based on the measurements obtained at time kT , the con-
troller predicts the dynamic behaviour of the plant over a prediction horizon
N in the future and solves optimal control problems on line (i.e. determines
the optimal input sequence), where tracking error, namely the difference be-
tween the predicted output and the desired reference, is minimized, subject
to constraints on the manipulated inputs and outputs.
To incorporate feedback and thus to make the MPC action robust to
disturbance and model-plant mismatch, the result of the optimization is
applied according to a receding horizon philosophy: at time kT only the
first input of the optimal command sequence is actually applied to the plant
until the next sampling instant. The remaining optimal inputs are discarded,
and a new optimal control problem is solved at time (k + 1)T . As new
measurements are collected, using the new system state at time (k + 1)T ,
the whole procedure (prediction and optimization) is repeated, moving the
control and prediction horizon forward [31, 32].
The process model plays, in consequence, a decisive role in the controller.
The chosen model must be able to capture the process dynamics to precisely
predict the future outputs and be simple to implement and understand.
Moreover the system model used to predict the future system behaviour at
each sampling time, is initialized by the actual system state. Since all state
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information is necessary for the prediction, the full state must be either
measured or estimated.
2.2.4 Performance indices
To measure the performance of the control strategies adopted, I will consider
the following metrics defined as integral expressions related to the control
error e = r − y.
1. The Integral of Squared Error (ISE)
ISE =
∫ t
0
e(τ)2 dτ (2-4)
ISE integrates the square of the error over time. ISE penalizes large
errors more than smaller ones.
2. The Integral Absolute Error (IAE)
IAE =
∫ t
0
|e(τ)| dτ (2-5)
IAE integrates the absolute error over time. It doesn’t add weight to
any of the errors in a systems response.
3. The Integral Time-weighted Absolute Error (ITAE)
ITAE =
∫ t
0
τ |e(τ)| dτ (2-6)
ITAE integrates the absolute error multiplied by the time over time.
It is a weighted version of IAE. It weights errors which exist after a
long time much more heavily than those at the start of the response.
2.3 System Identification
The design of a Model Predictive Control strategy requires a mathematical
model of the dynamical system to be controlled.
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Figure 2-8: Block diagram of Model Predictive Control. The MPC
is based on the idea of employing an explicit model of the plant to be con-
trolled which is used to predict the future output behavior. This prediction
capability allows solving optimal control problems on line, where tracking
error, namely the difference between the predicted output and the desired
reference, is minimized over a future horizon, possibly subject to constraints
on the manipulated inputs and outputs.
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Figure 2-9: Principle of Model Predictive Control. Starting from
the measurements obtained at time kT , the controller predicts the dynamic
behaviour of the plant over a prediction horizon N in the future and deter-
mines the input such that the difference between the predicted output and
the desired reference is minimized.
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Figure 2-10: System identification. System identification is a procedure
to build a mathematical model of the dynamics of a system from measured
input-output data.
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System Identification deals with the problem of building mathematical
models of dynamical systems based on the measured input-output data (Fig-
ure 2-10.
The identification of a dynamical model from data can be partitioned
into the following steps:
• Collecting the data. This is a very crucial (and most expensive)
step. The input-output data are recorded during a specifically designed
identification experiment. The purpose of the design of identification
experiments is to collect maximally informative input-output data by
choosing the signal to be measured, the sampling time at which carry
out the measurement and the inputs to be apply to the system that
has to be particularly suitable for identification.
• Selecting a model set and choosing a selection criterion. A spe-
cific model can be selected, on the basis of the observations, inside a
family of models (e.g. linear or non linear, deterministic or stochastic,
SISO or MIMO, continuous or discrete). These a priori assumptions
on the set of the admissible models can be guided by the user’s experi-
ence and improper past results. However any model can approximate
the true system behaviour, but the selection criterion is determined
by the planned use of the model in order to optimize its desired fea-
tures. From the same data can be obtained several models that can be
carried out following two major approaches: black-box and gray-box.
In black-box mode the model is completely derived from input-output
data and the model parameters are viewed as vehicles for adjusting
the fit to the data and do not reflect physical considerations about the
system. In the gray-box approach, first principles (e.g. Newton’s law)
and considerations on the physics of the system are used to partially
derive the model structure, while parameters or terms in the model
are determined by measurement data.
• Determining the "best" model in the set, guided by data.
The choose of the "best" model in the considered class is typically
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based on how the model perform when it attempt to reproduce the
measured data. The basic approaches to this, like the Prediction-
Error Minimization method and Least Square method [33], can be
used independently of the model structure used.
• Validating the model. The model validation involves various pro-
cedures (like Final Prediction Error and Akaike Information Criterion
[33]) to assess how the model relates to prior knowledge, to its intended
used and to observed data, better by using collection data different
from those used for identification. If the performance of the model is
not good enough, the model has to be reject; while it is considered
validated if it shows a good performance.
These choices are never univocal and can also involve some a priori
knowledge of the system, for instance in the design of the experiments re-
quired to collect input-output data. When the model does not pass the final
validation step , it is necessary to reconsider the choices and to restart the
identification procedure from the beginning or from an intermediate step
[34, 33, 35].
In my PhD work, I used System Identification approaches to identify
dynamical models of gene expression in order to implement MPC strategies.
I considered the grey-box approach with a predefined model structure
with unknown parameters to estimate linear and non linear SISO models in
state space form describing the dynamics of a Tet-OFF system in mammalian
cells. For the estimation of model parameters, I considered Least Squares
criterion that minimizes the sum of squared residuals. The residual for
the i -th data point ri is defined as the difference between the observed
response value yi and the fitted response value yˆi provided by the model
(ri = yi − yˆi). The identification was implemented in the MATLAB System
Idenfication toolbox (Mathworks Matlab R2016b) with the functions greyest
for the linear model and nlgreyest for the non linear model on the collected
input-output. The identification results will be shown in Sections 5.2 and
7.1 [33].
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Moreover, I used the black-box identification approach to derive a math-
ematical model in the state space form for the accumulation dynamics of a
small molecule in a microfluidic device (see Section 6.2). The model param-
eters were estimated by applying Prediction Error Minimization algorithm
implemented in the MATLAB System Idenfication toolbox (Mathworks Mat-
lab R2016b) with the function pem on the collected data [33, 36].
The input-output data were collected for dynamics identification of both
Tet-OFF system and the accumulation of a small molecule by using the
microfluidic-based platform that will be described in Chapter 3.
2.4 Kalman Filter
During in-vitro experiments it is only possible to measure directly system
output and not the states that are instead needed by MPC algorithm to
calculate the control input.
A standard approach for state estimation is to use a Kalman filter [37].
Using a LTI model, the past control inputs, and measurements, it gives an
estimate of the state of a system together with its uncertainty.
In this work the systems under investigation will be described by sin-
gle input-single output (SISO) discrete time model and the Kalman filter
addresses the problem of estimating the process state by considering the
following model:
x(k + 1) = Ax(k) + Bu(k) + v(k)
y(k) = Cx + w(k)
(2-7)
where x(k) ∈ Rn is the system state, u(k) ∈ R is the system input and
y(k) ∈ R is the output (measurement) of the system. A ∈ Rnxn is the
dynamic (or state) matrix, B ∈ Rnx1 and C ∈ R1xn are the input and
output matrices. The v(k) ∈ Rn and w(k) ∈ R are the process noise and
the measurement noise having normal distributions N(0,Q) nad N(0, R),
respectively.
At each instant k, by using a form of feedback control shown in the
Figure 2-11, the Kalman filter estimates the system state at some time and
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Time Update
(”Predict”)
Measurement Update
(”Correct”)
Figure 2-11: Discrete Kalman filter cycle. The time update projects
the current state estimate ahead in time. The measurement update adjusts
the projected estimate by an actual measurement at that time.
then obtains feedback in the form of noisy measurements [38]. The equations
for the Kalman filter are: time update equations and measurement update
equations. The time update equations are responsible for projecting forward
(in time) the current state and error covariance estimates to obtain the a
priori estimates for the next time step, thus the time update equations are
like predictor equations. The measurement update equations are responsible
for incorporating a new measurement into the a priori estimate to obtain
an improved a posteriori estimate (feedback), thus the measurement update
equations can be considered corrector equations. Let xˆ(k) the state estimate
at instant k, the obtained estimate error e(k) = x(k) − xˆ(k) and estimate
error covariance P
[
e(k), eT (k)
]
, at each instant k, the specific equations for
the time update are
xˆ(k + 1|k) = Axˆ(k|k) + Bu(k) (2-8)
Pp(k + 1) = AP(k)AT + Q (2-9)
The Equations (2-8) and (2-9) evaluate the optimal prediction of the
state xˆ(k + 1|k) and the prediction error covariance Pp(k + 1). The specific
equations for the measurements update are
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Kˆ(k + 1) = Pp(k + 1)CT (CPp(k + 1)CT +R)−1 (2-10)
xˆ(k + 1|k + 1) = xˆ(k + 1|k) + K(k + 1)(y(k + 1)−Cxˆ(k + 1|k))(2-11)
P(k + 1) = [I−K(k + 1)C]Pp(k + 1) (2-12)
The first task during the measurement update is to compute the Kalman
gainK(k+1) (Equation (2-10)); the second step (Equation (2-11)) computes
the optimal state estimate xˆ(k+1|k+1); the final step is to obtain the error
covariance estimate P(k + 1) via Equation 2-12.
In the implementation of the filter, the tuning of Q and R parameters
are usually off-line. In this work this parameters are chosen empirically.
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CHAPTER 3
Technological platform for
controlling living cells
In this Chapter, I present the experimental platform for the external control
of gene expression in a population of living cells. The requirements that the
entire setup have to satisfy are: to guarantee the physiological conditions
for the proper cells growth, to administer an external input and to monitor
in real-time the desired output. To fit all these needs, I took advantage of
a closed loop experimental platform based on a microfluidic device, a time-
lapse microscopy apparatus and a set of automated syringes all controlled
by a computer (Figure 4.1). Microfluidics allows to grow cells in living
conditions and to precisely change their environmental conditions in real-
time; the medium flowing in the microfludic device is modified by rising
or lowering the height of the two motorized syringes attached to the inlet
ports of the microfluidic device. Cells in the device can be imaged with the
microscope at a given sampling time, in order to quantify protein expression
in real-time. Thus from a Control Theory point of view, in the closed loop
experimental platform the cells in the microfluidic device represent the plant
to be controlled, the motorized syringes are the actuators and the sensor is
represented by the microscopy unit.
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Figure 3-1: Technological platform to control mammalian cells. Both
the main components of the experimental platform, as well as the informa-
tion flow, are highlighted in this scheme.
3.1 Microfluidics
Microfluidic cell culture technology has become a powerful tool in biolog-
ical research by enabling the study of living cells in a precisely controlled
microenvironment. Microfluidic devices have been used for everything from
miniaturization of molecular biology reactions to platforms for cell growth
and analysis [39, 40, 7, 41, 42, 43, 44, 45] .
A driving factor for increased use of microfluidics is the potential for
more productive experiments, that is, accomplishing the same or more using
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fewer resources (primarily less reagents, consumables, and time). Further-
more, microfluidic devices offer the unrivaled ability to precisely control and
perturb the environment of single cells while capturing their behavior us-
ing high resolution microscopy. The microfluidic devices are, essentially,
chips (mostly in PDMS), where fluid dynamics at the microliter scale are
exploited. The principle is to have an area where the cells are forced to
be in (cell trap), together with a series of channels to provide one or more
compounds to the trap in order to regulate cells environment or to collect
cells and fluids wastes.
While microbial microfluidic platforms have been successfully augmented
and used in several applications, mammalian studies have been slower to
adopt this approach due to the inherent complexities associated with mam-
malian microfluidic cell culture. The difficulties primarily arise because
mammalian cells are much more sensitive to small changes in pH, osmo-
larity, shear stress and other external factors than most of the microbial
model organisms. However, in [46] the authors developed a microfluidic de-
vice which can rapidly load a high density of cells into individual trapping
regions that are extremely isolated from the shear stress effects of the main
perfusion channel. They demonstrated the use of this platform in observ-
ing long-term growth of cell populations and in probing the response of a
fluorescent reporter cell line to dynamic stimulation.
In this Thesys I thus decided to use the microfluidic device designed by
Kolnik and colleagues [46] shown in Figure 3-2. The device consists of 33 in-
dividual cuboid culture chambers (each has a 230 mm by 230 mm footprint,
40 mm height) adjoined to a main perfusion channel of identical height via
a 50 mm wide opening on one side of each chamber. A separate channel for
application of a temporary vacuum runs parallel to the column of culture
chambers at a distance of 160 mm between the wall of this channel and the
closest wall of each cuboid chamber. In this manner a cell suspension can
flow into the main channel and upon the application of a temporary vac-
uum at gas-permeable PDMS interface, fluid containing cells is drawn into
the culture chambers. Once captured in the traps, the cells are effectively
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shielded from the fluid flow in the main channel and remain undisturbed
even at high flow rates (Figure 3-2 B).
A fluidic mixer network named the Dial-a-Wave (DAW) [47], joins to
the main perfusion channel and serves to deliver any desired waveform of
biochemical inducer for dynamic stimulation of cells inside the culture cham-
bers. The working principle of the DAW mixer is shown in Figure 3-3 and
it is to precisely combine two incoming fluid streams (inducer and standard
medium) in any desired ratio by adjusting the hydrostatic pressure at the
corresponding inlets in order to increase the pressure at one inlet while de-
creasing it at the other by exactly the same amount so that the flow rate
out of the junction remains constant. The DAW output signal is directed to
the cells via a channel which contains staggered chaotic mixers [48] to en-
hance diffusive mixing of the combined laminar flow streams before the fluid
reaches the main perfusion channel and the adjoining culture chambers.
For further details on the design, fabrication and cells loading refer to
Appendix A and [46].
3.2 Actuator
As mentioned previously, the DAW is designed to combine the inputs from
ports 6 and 7 of the microfluidic device in a precise ratio depending on the
inlet hydrostatic pressures. To set the mixing ratio, the pressure of one inlet
is increased and the other decreased by the same amount. By changing
the inlet pressures in an opposing manner, the flow rate out of the junction
remains constant and hence the flow to the cells is not altered (Figure 3-3
B).
By controlling the inlet pressures as a function of time, one can generate
precise waves of inducer concentration reaching the cell trap. Therefore, the
actuation aim is to establish this pressure difference.
To accomplish this, I used vertically two mounted linear actuators to
physically move the filled syringes up and down, thereby altering their hy-
drostatic pressures. The automated syringes are shown in Figure 3-4. Ob-
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serve that the syringes in this design have no plunger, since they are used
simply as tanks to store the media. Namely, each syringe will exert a hy-
drostatic force over the fluids in the channel that is simply proportional to
its height.
The actuation system comprises two linear guides; every linear actuator
is designed to move independently from the other; the motion is realised
through a stepper motor, while the transmission by using a timing belt and
two pulley. More details on the sizing and construction of the actuator can
be found in [49, 50].
3.3 Microscopy and Image analysis
To monitor cellular processes dynamics, I have taken advantage of an in-
verted fluorescence microscope (Nikon Eclipse Ti), shown in Figure 3-4,
equipped with an automated and programmable stage, an incubator to guar-
antee fixed temperature and gasses to cell environment and a high sensitivity
Electron Multiplying CCD (EMCCD) Camera (Andor iXON Ultra897). The
microscope and the camera can be programmed to acquire, at regular time
intervals, images from different points of the microfluidic device. At each
time point the microscope is programmed to acquire two types of images: a
bright field image (phase contrast image) and a fluorescence image.
Once cells have been imaged, image analysis algorithms can be applied
to estimate their fluorescence. To this end, I used an image processing
algorithm that is able to locate cells within each phase contrast image thus
identifying all the pixels belonging to cells. This information is used to
calculate the fluorescence expressed, for each fluorescent reporter, by the
cells. Additional informations on the microscope set-up for real time image
acquisition and on image analysis algorithm are available in Appendix A
and [50].
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Figure 3-2: Microfluidic device for mammalian cells.(A) Device de-
sign. Each of the 33 cuboid culture chambers is connected to a main per-
fusion channel that runs between ports 1 and 2. A separate air channel
between ports 3 and 4 allows the application of a temporary vacuum at
the PDMS interface to draw fluid from the main perfusion channel into the
culture chambers. Ports 57 comprise the DAW dynamic stimulation gener-
ator. (B) Vacuum loading of cells. Upon application of a vacuum in the
air channel at time 0, fluid containing cells is rapidly drawn into the culture
chambers and fills the traps within 2 min, at which point the vacuum is
turned off. Adapted from [46].
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Figure 3-3: Overview of DAW junction and staggered herringbone
mixers.(A) The flow direction in DAW junction is indicated by the black
arrows. The two inlets on the right come from ports 6 and 7. The flow
from the inlets converges in a ratio dependent on the inlet pressures of each.
The middle fork of the junction leads to the cell chambers while the two
outer forks lead to port 5, the shunt waste port. The staggered herringbone
mixers (SHM) immediately follow the DAW junction . It enhances diffu-
sive mixing of the combined laminar flow streams before the fluid reaches
the main perfusion channel and the adjoining culture chambers. (B) The
panel B represents the DAW junction, the weight of the black arrows are
an indication of the applied pressure. The ratio of the inputs from port 6
and 7 leaving the junction to the cell chamber is determined by each port’s
pressure By varying the pressures applied at the two inlets it is possible to
obtain different mixing ratios.
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Figure 3-4: Linear actuators and Nikon Eclipse Ti fluorescence mi-
croscope. The picture shows the fluorescence microscope (Nikon Eclipse
TI) and the linear actuator used in this study.
CHAPTER 4
Relay and Proportional-Integral
Control of Gene Expression from
the tetO7 -d2EYFP Synthetic
Network.
In this Chapter, I first introduce a microfluidics-based method to auto-
matically regulate gene expression from the tetracycline inducible promoter
in mammalian cells in real time. The approach is based on the negative-
feedback control engineering paradigm and it is validated in a monoclonal
population of cells constitutively expressing a fluorescent reporter protein
(d2EYFP) downstream of an inducible promoter consisting of a minimal
CMV promoter with seven tet-responsive operator motifs (CMVTET ). I
then describe two different control algorithms (relay and PI control) to force
a monoclonal population of cells to express an intermediate level of d2EYFP
equal to 50% of its maximum expression level for up to 3500 min with a
discrete control input that is either tetracycline-rich or standard growth
medium. I show that both the relay and PI controllers can regulate gene
expression at the desired level, despite oscillations (dampened in the case
of the PI controller) around the chosen set-point. This work has been par-
tially published in [51] demonstrating for the first time that it is possible to
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regulate the gene expression from an inducible promoter in a population of
mammalian cells using principles from control engineering.
4.1 The cellular model: Tet-OFF system
Control of gene expression in prokaryotes and lesser eukaryotes has been
achieved on both endogenous and synthetic networks (refer to Chapter 2).
However, transcriptional dynamics in mammalian cells is up to 1 order of
magnitude slower than in bacteria or simple eukaryotes, and therefore, the
time scale involved in the control of gene expression is much longer (days
instead of hours). Moreover, mammalian cells have much more stringent
requirements for culture conditions, such as temperature, pH and CO2 con-
centration which have to be taken into account in order to successfully main-
tain a cell culture in a microfluidic device over several days. These needs are
a distinctive feature of mammalian cells that have hindered the application
of automatic control to mammalian systems and therefore, as described in
Chapter 2, very few attempts have been made at applying Control Theory
to control processes in mammalian cells.
In order to design and implement a controller for gene expression in
mammalian cells, I decided to use as experimental testbed a simple inducible
promoter expressing a fluorescent reporter protein and whose transcriptional
activity can be modulated by varying the concentration of a small molecule
in the cell growth medium. Specifically, I used the tetrycycline-responsive
Tet-OFF system driving expression of a destabilised fluorescent protein, as
shown in Figure 4-1.
The Tet-OFF system, already described in the Section 2.1, has all the
characteristics required for a successful control: it has a very tight regula-
tion, hence low basal activity in the presence of the antibiotic tetracycline;
once tetracycline is removed from the growth medium, gene expression is in-
duced, with a high expression level compared to other inducible systems in
mammalian cells; tetracycline (or doxycycline) is non-toxic and well charac-
terised in the system in use. Moreover, the Tet-OFF system has been in use
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Figure 4-1: Experimental model: the tetO7 -d2EYFP monoclonal
cell line. (A) Scheme of tetO7 -d2EYFP circuit. The tetracycline trans-
activator protein (tTA) is constitutively expressed by a CMV promoter.
tTA binds the CMVTET promoter, which harbours seven tet-responsive el-
ements (tetO7 ) upstream of a minimal CMV promoter, thus driving the
transcription of a destabilized enhanced yellow fluorescent reporter pro-
tein (d2EYFP). Tetracycline binds tTA and prevents it from binding to
the CMVTET promoter, blocking the expression of the d2EYFP protein.
(B) Representative phase-contrast (left) and fluorescence (right) images of
tetO7 -d2EYFP cells grown in the absence of tetracycline.
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for decades, so that many cell lines and animal models using this promoter
are available.
The experimental testbed for assessing the feasibility of automatic control
of gene expression in mammalian cells consists of a monoclonal population
of cells, named tetO7 -d2EYFP cells, stably integrating the cassette shown
in Figure 4-1A where the Tet-OFF system drives the expression of a desta-
bilized enhanced yellow fluorescent reporter protein d2EYFP [52]. In the
Tet-OFF system, d2EYFP is expressed under the control of the CMVTET
promoter [17, 53], which is composed of a minimal CMV promoter with
seven tet-responsive operator motifs (tetO7 ), embedded in Chinese hamster
ovary (CHO) cells, constitutively expressing the tetracycline Transactivator
protein (tTA) (Figure 4-1).
In cells grown in standard growth medium, tTA is able to bind to the
CMVTET promoter, causing d2EYFP to be maximally expressed. Upon
addition of tetracycline to the culture medium, tTA detaches from the
CMVTET promoter, thus preventing the expression of d2EYFP.
4.1.1 Dynamical model of tetO7 -d2EYFP system
The tetO7 -d2EYFP cell line was first described in [54] and modeled us-
ing a three-dimensional a continuos-time linear time invariant dynamical
system. For each of the species (mRNA and correspondent protein concen-
trations), an equation expresses the change in concentration as the result
of a production term and a degradation term. The resulting model for the
tetO7 -d2EYFP system is:
dx1
dt
= v1
α1 + (1− α1)
(
θh2
θh2+Dh2
x¯2
)h1
K1
h1 +
(
θh2
θh2+Dh2
x¯2
)h1
− d1x1
dx3
dt
= v2x1 − (d3 +Kf )x3
dx4
dt
= Kfx3 − d3x4
(4-1)
39
where x1 represents the d2EYFP mRNA concentration, x3 is the unfolded
d2EYFP protein concentration and x4 is the folded d2EYFP protein concen-
tration. The constant value x¯2 represents the concentration of tTA protein,
constitutively expressed from the CMVTET promoter in tetO7 -d2EYFP cell
line. All parameters with the estimation procedure description are reported
in [54].
From a control perspective, the model in Equation (4-1) is a single input-
single output (SISO) dynamical system where the presence or absence of
tetracycline (represented by parameter D) is the system input and the sys-
tem output is the folded d2EYFP protein x4. Thus it can be rewritten in
state space form:
x˙ = Ax + Bu+ W, x(0) = x0, u ∈ {0, 1}
y = Cx
(4-2)
where
A =
−0.0101 0 00.0271 −0.0045 0
0 0.0012 −0.0032
 (4-3)
B =
0.07270
0
 (4-4)
C =
(
0 0 1
)
(4-5)
W =
8.52 · 10−60
0
 (4-6)
x(0) =
0.43192.6129
1.0212
 (4-7)
In the model 4-2, u ∈ R is the system input and accounts for the presence
(u = 1), or absence (u = 0), of tetracycline (or doxycyline) in the growth
medium; y ∈ R is the output (measurement) of the system; A ∈ Rnxn is
the dynamic matrix, B ∈ Rnx1 and C ∈ R1xn are the input and output
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Figure 4-2: The tetO7 -d2EYFP fluorescence in absence and in pres-
ence of tetracycline. (A-B) The red line under each graph represents the
respective tetracycline input provided to cells and the green line represents
the measured mean fluorescence of the tetO7 -d2EYFP cells (mean and stan-
dard deviation of technical replicates). (A) Fluorescence exhibited by the
cells in the presence of growth medium with no tetracycline. (B) Fluores-
cence exhibited by the cells in the presence of 100 ng/mL tetracycline in the
growth medium. (C-D) The red line under each graph represents the respec-
tive tetracycline input simulated, and the green line represents the simulated
fluorescence output. To simulate biological variability Gaussian noise with
zero mean and standard deviation equal to 1 is added to simulation output.
(C) Simulation of the model when no tetracycline is provided to the cells.
(D) Simulation of the model when a saturating concentration of tetracycline
is applied to the cells.
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matrices. x(0) ∈ Rnx1 is the initial state matrix and W ∈ Rnx1 matrix can
be considered as constant disturbance on the input.
In the gene expression control experiments, the measured average fluo-
rescence intensity of d2EYFP protein over the cell population is chosen as
system output. Indeed, when dealing with living cells, one of the major
issues is represented by the uncertainty affecting transcriptional and trans-
lational processes, introducing a remarkable cell-to-cell variability in mRNA
and protein production. Thus individual cells may express different level of
fluorescence. One of the way to account for this problem is to consider as
the system output the average fluorescence intensity expressed by all cells,
thus dampening the effects due to noisy measurements.
Figure 4-2 shows the simulated and measured fluorescence intensity ex-
pressed by the cells when they grow in standard medium or in tetracycline
rich medium. The experimental data and the simulation results are consis-
tent with the expected behaviour of the tetO7 -d2EYFP cells under inves-
tigation. Indeed, when standard medium is provided to the cells, the tTA
protein binds the CMVTET promoter and therefore d2EYFP fluorescence
level is expected to increase or to stay at a high steady state value (Figure
4-2 A-C). Viceversa when tetracycline is given to the cells, tTA detaches
from the CMVTET, thus d2EYFP fluorescence decreases, or stay at a low
steady state (Figure 4-2 B-D).
4.2 Implementation of the experimental con-
trol platform to steer gene expression in
mammalian cells
In order to carry out tetO7 -d2EYFP gene expression, I used the integrated
experimental platform described in the Chapter 3 and shown in Figure 4-3,
consisting in a disposable microfluidic device, a time-lapse microscope, and
a set of automated syringes, all controlled by a computer. This platform en-
ables both monitoring of fluorescent protein levels in real time, and control
of the cellular environment. The microfluidic device presented in Chapter 3
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was used to trap cells in a micrometric chamber. Either culture medium or
an inducer molecule can be supplied to the chamber by changing the rela-
tive heights of two motorized syringes that are connected to it via capillary
tubes, one containing just culture medium and the other culture medium
plus the inducer molecule (tetracycline). The fluorescence produced by cells
y is imaged by the microscope at regular sampling times and quantified via
an image segmentation algorithm, which computes the average fluorescence
intensity across the cells in the image ym (see Appendix A for details on
image segmentation). The measured fluorescence ym is then compared to
the desired fluorescence value r, and a control algorithm computes the nec-
essary amount of inducer molecule u to be administered to the cells in order
to minimize the control error e and then moves the syringes accordingly.
In principle, the hydrostatic pressure difference between the two syringes
can be used to provide any desired concentration of the inducer molecule
by mixing the two fluids through proper adjustment of the heights of the
two syringes. However in this first pilot study a discrete control input was
used, that is no inducer (i.e. just culture medium) or a single predetermined
concentration of the inducer molecule is provided to the cells.
When designing a control platform for controlling a gene network in
mammalian cells there are several constraints that have to be taken into
account. Indeed during control experiments mammalian cells are subject
to different types of stress that real-time imaging and microfluidics induce,
such as phototoxicity, shear stress, overgrowth.
Phototoxicity is a deleterious effect of high-energy light irradiation that
causes the production of ROS species, cell cycle arrest and ultimately cell
death. It is an inevitable effect in time-lapse fluorescence microscopy over
long periods of time, but some fine-tuning of acquisition parameters may
limit the problem [55]. The mechanical stress that the flow induce in cells can
be avoided in the microfluidic device by reducing the filling time of cell traps;
however, its drawback is that full exposure to the desired concentration of
drug occurs only after 10 minutes after the switching of the media. Hence,
a time resolution of 15 minutes between experimental points is chosen as
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Figure 4-3: Control platform. Cells are grown in a microfluidic de-
vice within a temperature- and CO2-controlled environment under an in-
verted fluorescence microscope. Images are acquired at regular sampling
time y, and quantification of the fluorescence is performed via an image-
segmentation algorithm. The measured level of fluorescence ym is compared
to the desired reference value r obtaining the control error e. The con-
trol algorithm minimizes the control error and computes the input u to be
provided to the cells and moves the syringes containing either untreated or
tetracycline-treated medium.
a good trade-off among reduction of phototoxicity, approximation of drug
concentration, and resolution of data for fitting and analysis. Finally, the
dimension of the cell traps in the microfluidic device limits the length of the
experiment to a maximum of 3− 4 days in order to avoid cell death because
of overcrowding.
4.3 Control strategies and control objective
The task of controlling a gene network in mammalian cells has to face a
number of challenges due to the biological nature of the system being con-
trolled and to technical limitations. The choice of the type of controller is a
trade-off between robustness and accuracy. In the case of the tetO7 -d2EYFP
system, the main constraints that the control law has to satisfy are:
1. It is possible to either feed standard medium or tetracycline rich medium
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to cells, but not intermediate concentrations.
2. The output (d2EYFP fluorescence intensity) can be measured only
at sampling time equal or greater than 15 minutes in order to avoid
photoxicity.
Thus in this initial stage the control law should be as simple as pos-
sible, I thus started by implementing two simple controllers: Relay and
Proportional-Integral (PI).
4.3.1 Relay control
The first control scheme I developed was the relay controller [22]. As already
mentioned in the Chapter 2, the relay controller requires only the compu-
tation of the control error at each sampling time e(kT ), where T = 15
minutes, whose sign dictates which input must be provided to the cells.
Specifically, cells are treated with standard growth medium for the next 15
min if e(kT ) > 0 or tetracycline-containing medium otherwise.
The drawback of this controller is that it does not take into account the
dynamics of the system and thus can be slow in converging to the desired
set-point and show marked oscillations around it. In addition, when the
measured value ym is very close to the reference, the control error can rapidly
change sign, thus causing the control input to continuously switch between
the two growth media (chattering phenomenon [23]). To avoid chattering,
a hysteresis interval  equal to 5% of the reference value is added to the
controller. Thus the relay control law used to regulate the tetO7 -d2EYFP
gene expression can be expressed as follows:
u(t) =
{
uON = 1 if e(t) ≥ 
uOFF = 0 if e(t) < −
(4-8)
4.3.2 Proportional-Integral regulator
As detailed in Chapter 2, a PI controller is very useful and it is capable of
solving a wide range of industrial control problems [22]. The output of PI
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controller uˆ(t) as a function of the control error e(t) defined as
uˆ(t) = Kpe(t) +Ki
∫ t
0
e(τ) dτ (4-9)
where the gains Kp and Ki have to be tuned to optimize controller yield.
Since in the tetO7 -d2EYFP system, cells can be fed with or without
Tetracycline in a mutually exclusive manner, the continuous signal uˆ(t) has
to be modulated in a discrete control input that is restricted to be either
ON (standard medium) or OFF (tetracycline rich medium) so that:
u(t) =
{
uMAX = ON kT ≤ t < (k + dk)T
uMIN = OFF (k + dk)T ≤ t < (k + 1)T
(4-10)
Therefore at each sampling time kT the control input uˆ(t) is encoded as the
duty cycle dk of a square wave with a period of 15 minutes according to the
following law:
dk =
uˆ− uMIN
uMAX − uMIN (4-11)
where uˆ is the output of the PI regulator saturated between uMIN = 0 and
uMAX = 1.
This modulation introduces a saturation on the PI output uˆ. As already
described in Chapter 2, the presence of a saturation downstream to the PI
can lead to a break of the feedback loop affecting the control performance
[22]. To overcome this issue I have implemented the anti-windup scheme
described in Chapter 2 (Figure 2-7) considering a feedback gain Kt = .5.
The proportional and integral gains, Kp = 4.08 and Ki = 0.012 were
calculated with the Ziegler-Nichols’ closed-loop tuning method [22] applied
to the mathematical model of the tetO7 -d2EYFP described by the Equations
(4-2).
4.3.3 Control objective
In order to assess whether automatic control of gene expression in mam-
malian cells is feasible, I chose as control objective set-point regulation where
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cells are required to express 50% of their maximum fluorescence for up to
3500 minutes.
The maximum fluorescence is estimated during the calibration phase at
the beginning of each control experiment. During the calibration phase of
180 minutes, the cells in microfluidic device are fed with standard medium
so that d2EYFP is maximally expressed. The images are acquired with a
sampling time of 15 minutes and the fluorescence value is estimated as the
time- and population-average fluorescence expressed by the cells during the
first 180 minutes. The calibration phase is also needed to allow the cells to
adapt to the microfluidic environment.
4.4 Numerical simulations of the Relay and PI
controllers.
To validate the relay and PI control strategies, I simulated the control of
tetO7 -d2EYFP gene expression by using the dynamical model described by
the Equations (4-2) as a proxy for the the behaviour of tetO7 -d2EYFP cells.
Thus the control objective was to regulate the output y of model in order
to the reference signal r, calculated as the 50% of the steady state of the
model’s output for a control input equal to 1 (i.e. cells grown in standard
medium). In order to account for measurement noise, a gaussian noise with
zero mean and standard deviation equal to 1 is added to the model output
before being fed back to the controller. For the sake of clarity and to make
comparison with the experimental results easier, the simulated tetracycline
concentration is reported in red in the Figure 4-4 as (1− u) where u is the
input computed by the controllers. Thus, when the value of red signal is
high, the cells are fed with tetracycline, viceversa standard growth medium
is provided to the cells when the red signal is low (red line in Figure 4-4).
Figures 4-4 A and B show the simulation results for the set-point control
task using the relay and PI controllers, respectively. In both cases the con-
trollers were able to control the output of the model y to the desired value
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r but, as expected, oscillations around the set-point are present. These os-
cillations are due to the controllers’ choice, as both relay and PI are not
model-based and hence not able to predict the system’s behaviour. More-
over, the controller performance are negatively affected also by the binary
nature of the control input.
4.5 In vitro experimental implementation of
the Relay and PI controllers.
In order to perform in vitro control experiments, the tetO7 -d2EYFP cells
were loaded in the microfluidic device and allowed to attach and grow for 24
hours under perfusion conditions in a cell culture incubator. The device was
then moved to the inverted microscope, and image acquisition and control
experiment were started.
The control task was to reach and maintain a set-point equivalent to
50% of the fluorescence value measured during the calibration phase. This
value was obtained by imaging the cells in the absence of tetracycline for
180 minutes at 15 minutes intervals and then calculating the time-averaged
value of the fluorescence across the images.
Figure 4-5 A and B show the results of the in vitro control experiments
with the relay and PI controllers, respectively. In agreement with numerical
simulations (Figure 4-4), the system is unable to settle on the reference value
but persistently oscillates around it for the whole length of the experiment
(3500 minutes). The behaviour of the relay controller (Figure 4-5 A) is
very close to that of the numerical simulations (Figure 4-4 A), exhibiting
undamped oscillations around the set-point.
In the case of the PI controller (Figure 4-5 B), the oscillations have a
decreasing amplitude with time, as predicted in the simulation . One differ-
ence between the experiment and the corresponding simulation in this case
(Figure 4-4 B) is the longer initial delay following tetracycline administra-
tion before the fluorescence starts to decrease. Nevertheless, the controller
is able to react accordingly, and the fluorescence value of the cells is slowly
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brought toward the desired set-point. This slight difference in the initial
dynamics is due to intrinsic variabilities caused by experimental conditions
and cell batches.
Despite the oscillations around the set-point value, these experiments
demonstrated that the developed control strategies are suitable to automatic
control of gene expression in mammalian cells is feasible. This work was
partially published in [51] and it was the first time automated control of
gene expression from an inducible promoter has been achieved in mammalian
cells.
The control performance can be greatly improved by moving to a model−based
control strategy such as Model Predictive Control.
The implementation of an MPC strategy to regulate gene expression in
mammalian cells will be the topic of the next Chapters.
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Figure 4-4: Numerical simulation of set-point control of tetO7 -
d2EYFP gene expression. Simulations of control experiments performed
on the tetO7 -d2EYFP dynamical model by means of Relay with hysteresis
with equal to the 5% of the set-point (A) and PI (B) controllers. The red
line under each graph represents the respective tetracycline input simulated
u, and the green line represents the simulated fluorescence output y. The
reference value (r, blue line) is calculated as the 50% of the high steady state
of the model’s output, here normalized to 1.
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Figure 4-5: In vitro set-point control experiments. Two in vitro set-
point control of tetO7 -d2EYFP gene expression by means of Relay with
hysteresis with equal to the 5% of the set-point (A) and PI (B) controllers.
The control action starts at time t = 0 min. The value of the desired level of
fluorescence (r in blue) is calculated as the 50% of the d2EYFP fluorescence
quantified before time t = 0 min. during the calibration phase of 180 min
The red line under each graph represents the control input u (tetracycline
provided to cells in the microfluidic device), and the green line represents
the measured mean d2EYFP fluorescence (system output y, in green)
CHAPTER 5
Model Predictive Control of Gene
Expression from the
tetO7 -UbV 76GFP synthetic
network with a Discrete Control
Input
In this Chapter, I describe the construction of an inducible synthetic gene
network in mammalian cells based on Tet-OFF system, which I named
tetO7 -UbV 76GFP, exhibiting faster dynamics than tetO7 -d2EYFP described
in the Chapter 4. Then I discuss the use of the experimental platform pre-
sented in Chapter 3 to identify a dynamical model of the tetO7 -UbV 76GFP
system . I show that this experimental set-up allows to infer quantitative
dynamical models of transcriptional processes from measured input and out-
put data. These models are useful to predict the behaviour of the system
in response to various stimuli and to design feedback control strategies. Fi-
nally, I present a Model Predictive Control strategy to regulate the tetO7 -
UbV 76GFP gene expression with a discrete control input. I will show how
the application of a model based control strategy drastically improves the
control performance.
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5.1 Tetracycline inducible promoter driving the
fast-degrading reporter protein UbV 76GFP
The results presented in Chapter 4 actually demonstrate that microfluidics
based automatic control of gene expression from an inducible promoter in
mammalian cells is feasible. In Chapter 4, I presented the results obtained
in controlling gene expression by using two controllers: a relay controller
and Proportional-Integral (PI) controller. Despite the PI control scheme
improves control performance compared to the relay, still oscillations around
the reference value persist. Long timescales of transcriptional dynamics in
mammalian cells are responsible for the low performance of the relay and
PI control strategies. Therefore, I chose to deal with the inherent inertia
of the biological system by applying model-based control strategies such as
the Model Predictive Control (MPC) [8, 9, 11]. Indeed, the MPC allows to
reduce or eliminate the oscillations around the reference value thanks to its
predictive nature.
The technological platform for controlling living cells (discussed in Chap-
ter 3) allows a control experiment to last at most 3 days, after which the
microchannels clog because of cell proliferation. Therefore, I decided to mod-
ify the tet07 -d2EYFP system used for testing the relay and PI controllers
in Chapter 4 by replacing the fluorescent reporter protein (d2EYFP) with
a reporter with faster mRNA and protein degradation rates, thus yielding a
gene network with faster transcriptional and translational dynamics. This
modification allows to run control experiments of shorter duration (less than
3 days).
Specifically, in this new tetO7 -UbV 76GFP network, the Tet-OFF sys-
tem [17, 53] drives the expression of a fluorescent reporter gene with fast-
degrading mRNA and protein. In order to a have a fast-degrading protein,
I chose the UbV 76GFP whose half-life is in the order of minutes rather than
hours as in the case of d2EY FP , thanks to an ubiquitonanion signal tagging
the protein for degradation by the proteasome [56].
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Figure 5-1: Scheme of the tetO7 -UbV 76GFP circuit. A Tetracycline
transactivator (tTA) is constitutively expressed from the CMV promoter,
and it is able to activate the transcription of the UbV 76GFP reporter from
the CMVTET (or tetO7 ) promoter on a separate transcriptional unit. The
3’UTR sequence is cloned downstream of the UbV 76GFP to increase its
degradation rate. Tetracycline binds to the tTA, blocking its activity.
In order to enhance the degradation rate of the mRNA encoding for the
reporter protein, the endogenous 3′ Untraslated Region (3′UTR) of the Hes1
gene was cloned downstream the UbV 76GFP sequence. Indeed, it has been
hypothesized that this sequence contains destabilizing signals responsible
for the rapid degradation of Hes1 mRNA [57]. A scheme of the tetO7 -
UbV 76GFP system under investigation is reported in the Figure 5-1.
In these cells, the destabilized fluorescent reporter protein UbV 76GFP is
expressed under the control of the CMVTET promoter [17, 53], which har-
bours seven tet-responsive elements (tetO7 ) upstream of a minimal CMV
promoter, embedded in CHO cells, constitutively expressing the tetracycline
Transactivator (tTA) protein. In cells grown in standard growth medium,
tTA protein is able to bind the CMVTET promoter causing UbV 76GFP to
be maximally expressed. Upon addition of tetracycline, or its homologous
doxycycline, to the culture medium, tTA detaches from the CMVTET pro-
moter thus preventing the expression of UbV 76GFP.
Model identification and the control of tetO7 -UbV 76GFP system will be
the subject of the next sections.
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5.2 Modeling tetO7 -UbV 76GFP system dynam-
ics in mammalian cells
The microfluidic-based experimental platform presented in the Chapter 3 can
be used also in open-loop in order to infer quantitative models of transcrip-
tional processes from measured input and output time-series data. Thus,
I took advantage of this set-up in order to identify dynamical model for
tetO7 -UbV 76GFP system.
As already described in the previous section, the biological system under
investigation is CHO Tet-OFF cell line, expressing constitutively the tTA
protein, in which the destabilised fluorescent reporter UbV 76GFP is stably
integrated under the control of CMVTET promoter. In untreated medium,
the cells express UbV 76GFP protein, but expression is inhibited upon addi-
tion of tetracycline to the culture medium (Figure 5-1).
In order to perform identification experiments, tetO7 -UbV 76GFP cells
were loaded in the microfluidic device and allowed to grow for 24 hours
under perfusion conditions in a cell culture incubator. The device was then
moved to the inverted microscope, and the images acquisitions and the iden-
tification experiment were started (for more details on experimental protocol
see Appendix A).
In identification experiments, the strategy I followed was to give as in-
put to the cells in the microfluidic device, a series of pulses of tetracycline
concentration with variable duration but fixed amplitude by means of the
automated syringes, and to measure UbV 76GFP fluorescence over cell pop-
ulation, which I considered as the output of the system [58].
Experimental data. The green fluorescence of tetO7 -UbV 76GFP cells
was captured for up to 20 hours each 15 minutes. During this interval,
tetracycline rich medium at the concentration of 100 ng/ml and standard
growth medium were alternatively provided to the cells chamber (Figure 5-
2). The concentration of tetracycline in the cells chamber was tracked with
a red fluorescent dye (Sulforhodamine), so that it was possible to obtain a
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Figure 5-2: TetO7 -UbV 76GFP experimental data. (A) The green sig-
nal is the average of the UbV 76GFP fluorescence across the cell population
measuring during the experiment. This signal is considered the output of the
system. (B) The red signal is the fluorescence of the dye added to the tetra-
cycline rich medium measured during the experiment. It is high when the
cells are fed with tetracycline whereas it is low when the standard medium
is provided to the cells.
time profile of the input provided to the cells by measuring the fluorescence
of the medium in the red spectrum (Figure 5-2 B). The average fluorescence
of the cells’ population, in the green spectrum, which is proportational to
the average expression of UbV 76GFP protein, represents the system output
(Figure 5-2 A).
The representative dataset shown in Figure 5-2 is consistent with the
expected behaviour of the tetO7 -UbV 76GFP system under investigation. In-
deed, when standard medium is provided to the cells, the tTA binds the
CMVTET driving the expression of UbV 76GFP fluorescent protein. Vicev-
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ersa when tetracycline is given to the cells, tTA detaches from the CMVTET
promoter, thus preventing the expression of UbV 76GFP protein. Therefore,
the fluorescence level is expected to reach a high steady state value when the
cells are fed with standard medium. It should instead reach a lower steady
state when tetracycline is provided. At the beginning of the experiment, the
cells exhibit a high level fluorescence because the cells are grown in standard
medium.
5.2.1 Grey box identification
In order to obtain a mathematical model for tetO7 -UbV 76GFP system, I
followed the System Identification procedure described in Section 2.3 by
starting from the input-output data depicted in Figure 5-2 where the sys-
tem input is represented by pulses of tetracycline rich medium and standard
medium and the system output is the average intensity of the cells fluores-
cence in the green spectrum.
In order to identify a dynamical model of the tetO7 -UbV 76GFP sys-
tem with biologically meaningful parameters, I decided to use a gray-box
identification approach with a predefined model structure with unknown
parameters. I derived a set of three linear differential equations describ-
ing the production and degradation of the mRNA (Equation (5-1)), the
unfolded reporter protein (Equation (5-2)) and the folded reporter protein
(5-3)). Specifically, I assumed distinct dynamics for the unfolded (inactive)
and folded (active) forms of the UbV 76GFP reporter protein in order to take
into account UbV 76GFP protein maturation time needed for correct protein
folding [56].
Letting x1 be the UbV 76GFP mRNA concentration, x2 the unfolded
UbV 76GFP protein concentration and x3 the folded UbV 76GFP protein con-
centration, the tetO7 -UbV 76GFP system can be described as follows
dx1
dt
= −d1x1 + β1u (5-1)
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dx2
dt
= α2x1 − d2x2 (5-2)
dx3
dt
= α3x2 − d3x3 (5-3)
with u ∈ {0, 1}.
In the Equation (5-1), u is the only external input to the model and
it is assumed to be equal to 1 when cells are fed with standard medium,
and 0 when tetracycline is provided to the cells (Figure 5-3 B). d1 is a
linear degradation coefficient for the mRNA and the input coefficient b is
its production rate. In the Equations (5-2) and (5-3), d2 and d3 are the
degradation rates of the unfolded UbV 76GFP and folded UbV 76GFP protein,
and α2 and α3 represent the translation rate and the folding rate respectively.
The resulting SISO LTI model is:
x˙ = Ax + Bu, x(0) = x0 u ∈ {0, 1}
y = Cx
(5-4)
where A =
−d1 0 0α2 −d2 0
0 α3 −d3
 ,B =
β10
0
 and C = (0 0 1)
I have named this set of equations the UbV 76GFP.DI model, where DI
stands for Discrete Input.
The model parameters were obtained by using the grey-box identification
technique described in [34, 59], and implemented in the MATLAB System
Idenfication toolbox (Mathworks Matlab R2016b) with the function greyest,
on the input-output data in Figure 5-3, where the output is the average cells
fluorescence of the reporter protein (x3 in (5-3)) and the input represents
the tetracycline rich or standard medium (u in (5-1)).
In order to validate the model, I used the following performance metrics:
Akaike’s Final Prediction Error (FPE), Information Criterion (AIC) and the
fitting percentage (FIT%) [34, 36].
FPE and AIC metrics can be used to evaluate the ability of the identified
model to capture the system response to a known input signal.
These performance indeces are computed as:
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FPE =
1 + d
N
1− d
N
V (5-5)
AIC = log
(
V
(
1 + 2
d
N
))
(5-6)
where d is the total number of estimated parameters and N is the length of
the data record. V is the loss function defined as:
V =
1
N
N∑
i=1
2 (i, θN) (5-7)
where θN is the vector of estimated parameter and 2 (i, θN) is the prediction
error.
The Fitting Percentage (FIT%) measures how well the response of the
model fits the estimation data, expressed as a percentage. It is defined as:
FIT (%) = 100
1−
√∑N
i=1 (yˆi − yi)2√∑N
i=1
(
yˆi − ¯ˆy
)2
 (5-8)
where for i-th datapoint, yˆi is the measured output data, ¯ˆy is its mean and
yi is the model output in response to the input that leads to the real system
output yˆi.
The estimated model parameters are reported in Table 5-1, while the
response of the identified model to the input signal is shown in Figure 5-3
(A). The evaluated performance indices are reported in the Table 5-2.
5.3 In vitro regulation of tetO7 -UbV 76GFP sys-
tem with discrete control input
In order to implement a control strategy to steer UbV 76GFP expression, I
employed the experimental platform described in the Chapter 3 and used
also for controlling the tetO7 -d2EYFP (see Chapter 4 and [51]).
Briefly it consists of a closed loop control platform based on microfluidic
device, featuring a computer implementation of the control algorithm and
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Figure 5-3: Grey box identification of the UbV 76GFP model. (A) The
solid blue line is the output of the state-space model identified with greyest
function from MATLAB System Idenfication toolbox (Mathworks Matlab
R2016b). The green dashed line is the average cell fluorescence measured
during the experiment. (B) The black signal is the ideal input and it can
be either 0 (tetracycline-rich medium) or 1 (standard medium). The same
input signal is used both to identify and validate the model.
an inverted fluorescence microscope. The tetO7 -UbV 76GFP cells are grown
in the microfluidic device and are imaged by a time-lapse epifluorescence
microscope. The computer uses the images to quantify cells fluorescence
and compare it with the desired fluorescence amount at each sampling time.
On the basis of the control error, the control algorithm computes the con-
trol action and varies the height of two motorized syringes filled with either
tetracycline rich medium or standard medium. Hydrostatic pressure gener-
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Table 5-1: Parameters of tetO7 -UbV 76GFP model identified by with the
grey box identification approach
Parameter Description Value
d1 [min
−1] degradation rate of UbV 76GFP mRNA 0.0256
d2 [min
−1] degradation rate of UbV 76GFP unfolded protein 0.0257
d3 [min
−1] degradation rate of UbV 76GFP folded protein 0.0045
β1 [min
−1] production rate of UbV 76GFP mRNA 0.0029
α2 [min
−1] production rate of UbV 76GFP unfolded protein 0.0501
α3 [min
−1] production rate of UbV 76GFP folded protein 0.0209
Table 5-2: Values of the performance indices for the tetO7 -UbV 76GFP model
FPE 6.50 ∗ 10−3
AIC −5.0362
FIT 64.3%
ated by the relative difference in the heights of the two syringes drives the
flow in the microfluidic device and determines the type of growth medium
cells will sense in the chamber.
As already mentioned in the previous sections, in the tetO7 -UbV 76GFP
system, the Tta protein drives the expression of the UbV 76GFP reporter
protein in CHO cells (Figure 5-1). It can be viewed as a single input-single
output (SISO) dynamical system. The input u(t) describes standard medium
(1) or tetracycline-rich medium (0). The output y(t) is the measured average
level of fluorescence of the UbV 76GFP protein over the cell population,
which can be used as a proxy of the protein concentration [60].
In the control experiment, the cell fluorescence is imaged at 15 minutes
intervals. This sampling time T is chosen as trade-off among reduction of
phototoxicity and resolution of data for fitting and analysis.
5.3.1 Control Objective and control input
The control task consists in driving a growing population of CHO tetO7 -
UbV 76GFP cells to reach and maintain over 2500 minutes a fixed amount of
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the UbV 76GFP protein equal to 50% of the maximum fluorescence exhibited
by the cells when grown in standard medium. Specifically, the control ob-
jective is a set-point regulation where the reference value r(t) is calculated
as the 50% of the average of the fluorescence level expressed by the cells
during the calibration phase that occurs at the beginning of each control ex-
periment. In this phase, the cells, which were grown overnight in standard
medium thus causing the UbV 76GFP to be maximally expressed, are loaded
in the microfluidic device and kept in standard medium for 180 minutes.
This calibration phase allows to set the unit of measure of fluorescence that
are subject to change in every experiment due to technical (fluorescent lamp
usage) and biological (expression noise) issues. During the calibration phase
the maximum fluorescence reached by the cells in quantified and it is then
used to set the unit of measure of the reference signal.
The control input u is a discrete signal that is restricted to be either 1
(standard medium) or 0 (medium with tetracycline at a concentration of 100
ng/ml ) so that:
u(t) =
{
uMAX = ON kT ≤ t < (k + dk)T
uMIN = OFF (k + dk)T ≤ t < (k + 1)T
(5-9)
5.3.2 Control strategy: Model Predictive Control
In order to regulate the UbV 76GFP protein expression in CHO cells, I decided
to implement a Model Preditive Control (MPC) feedback law, which has
already been applied to control biological systems (refer to Chapter 2).
As described in the Section 2.2.3, given a dynamical model of the system
being controlled and desired temporal profiles for the system’s outputs, MPC
aims at finding the control input to minimize the deviation between the
outputs of the model and the desired outputs. As model of the tetO7 -
UbV 76GFP system, I chose the UbV 76GFP.DI model in the Equation (5-4).
Moreover, to speed up the computation process I decided to use a discretised
version of the UbV 76GFP.DI model, assuming that the input is piece-wise
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constant during the sampling period T (zero-order hold method described
in [61]). I thus obtained
xk+1 = Axk + Buk, uk ∈ {0, 1} x(0) = x0
yk = Cxk
(5-10)
where xk =
x1(kT )x2(kT )
x3(kT )
 are the system states, uk = u(kT ) is the control
input and yk = y(kT ) is the system output with k being a natural number
(k ∈ [1, 2...]). The matrices A, B and C are:
A =
a11 0 0a2,1 a2,2 0
a3,1 a3,2 a3,3
 (5-11)
B =
b1b2
b3
 (5-12)
C =
(
0 0 1
)
(5-13)
the discretised model preserves its dynamics, with eigenvalue of A being in
modulus less than 1 (system asymptotically stable [22]).
At each sampling time kT , starting from the experimental data, the MPC
controller uses the discrete model (5-10) to predict the dynamic behaviour
of the tetO7 -UbV 76GFP system over a defined prediction horizon and to
determine the input such that an open−loop objective function is minimized
[28, 32].
As the open−loop objective function to be minimised, I chose the squared
control error (SSE), defined as:
SSEk =
k+N∑
i= k+1
(
N + 1 + k − i) 2i
=
k+N∑
i= k+1
(
N + 1 + k − i) (ri − yi)2
(5-14)
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where N = 15 defines the length of the prediction horizon in terms of sam-
pling intervals (corresponding to 225 minutes). (N+1+k− i) is a weighting
factor that weights more the control error samples at the beginning of the
prediction horizon than those at the end in order to guarantee faster correc-
tions of output deviations from the reference r [11].
Specifically at each sampling instants kT , starting from the current state
information x(kT ) the MPC solves the following open loop optimal control
problem
min
{dk+1,...,dk+N}∈[0,1]
SSEk
s.t.
xi+1 = Axi + Bui
yi = Cxi
xk is given
ui = di (uMAX − uMIN)
yi ∈ [0, 1]
i ∈ {k + 1, . . . , k +N}
(5-15)
The state measurements enter the system via the initial conditions at the
sampling time x(kT ), i.e. the model is initialized by the actual system state.
Since all state information is necessary to initialize the model, the full state
must be either measured or estimated. In in vitro tetO7 -UbV 76GFP control
experiments only the system output yk (i.e. UbV 76GFP fluorescence) can be
measured, thus the system states xk are reconstructed with a Kalman filter
[37], implemented as described in section 2.4.
The solution to the optimal control problem in (7-6) is an array of N
optimal duty cycles di and only the first element of this array (dk in Figure
5-4) is provided to the cells, in order to incorporate the feedback the optimal
open loop input (dk) is applying only until the next sampling instant (k+1)T
when the entire procedure (prediction and optimization) is repeated.
The optimization is carried out by adopting the Matlab implementation
of the Genetic Algorithm described in [62].
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u(t)
tkT (k+1)T
ON
OFF
dk
Figure 5-4: Discrete input signal. During each sampling time T the input
signal is a pulse whose duration ton is defined by the duty-cycle dk = tonT
with dk ∈ [0, 1].
5.3.3 Results
In order to test the MPC strategy described above, I simulated the control of
tetO7 -UbV 76GFP gene expression by using the UbV 76GFP.DI model in the
Equation (5-4) as a proxy for the behaviour of tetO7 -UbV 76GFP cells. The
control task was set−point regulation calculated as the 50% of the steady
state of the model’s output for a control input equal to 1 (i.e. cells grown in
standard medium).
The result of simulation are reported in the Figure 5-5. For the sake
of clarity and to make comparison with the experimental results easier, the
simulated tetracycline concentration is reported in the Figure 5-5 (B) as
(1 − u) where u is the input computed by the MPC controller inferred in
Section 5.3.2. Thus, when the value of red signal is high, the cells are fed
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with tetracycline, viceversa standard growth medium is provided to the cells
when the red signal is low (Figure 5-5 (B)).
As shown in Figure 5-5 the controller is able to reach the control reference
and to maintain its value without exhibiting oscillations at steady state, thus
demonstrating that the developed control strategy is suitable to regulate the
system under investigation.
The numerical results prompted the experimental implementation of the
control strategy. To perform in vitro experiments, I integrated the devised
control law into the experimental platform. The tetO7 -UbV 76GFP cells are
loaded in the microfluidic device and allowed to grow in standard medium
for 24 hours under perfusion conditions in cell culture incubator thus reach-
ing their maximum level of fluorescence. Then the device is moved to the
inverted microscope and the control experiment starts. At the beginning
of each experiment, the cells are kept for 180 minutes in standard growth
medium (calibration phase) in order to calculate their maximum fluorescence
level, since the reference signal is expressed as a percentage of this value.
The control task is the same as for the numerical simulations, that is
a set−point control task forcing the cell population to express an average
fluorescence equal to 50% of their maximum fluorescence level calculated
during the calibration phase.
As shown in Figure 5-6 the control action works effectively in keeping
the output, namely the measured fluorescence, close to the desired set point
for 2500 minutes.
Thus the results achieved in vitro (Figure 5-6) are consistent with the
corresponding numerical simulations (Figure 5-5).
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Numerical simulation: set point control
Figure 5-5: Numerical simulations of control tetO7 -UbV 76GFP
model by means of MPC with discrete control input. (A) The MPC
algorithm is applied to control the dynamical model of the tetO7 -UbV 76GFP
expression to a constant reference signal (r in blue). The set point is equal
to 50% of the high steady state of the model’s output, here normalized to
1. The green line is the system output y. (B) The control input is shown
in red (u high level: tetracycline; low level: standard medium). The simu-
lation was performed by controlling the dynamical UbV 76GFP.DI model in
the Equation (5-4).
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Figure 5-6: In vitro control of tetO7 -UbV 76GFP expression by
means of MPC with discrete control input. (A) In vitro set-point
control experiment was performed on the tetO7 -UbV 76GFP cells. The con-
trol action starts at time t = 0. The set point (r in blue) is equal to 50 of
the UbV 76GFP fluorescence value quantified during the calibration phase,
here normalized to 1. The green line is the average fluorescence measured
over the population cells, ym. (B) The input signal u, computed in real-
time by the control algorithm, is shown in red: a high signal corresponds to
tetracycline rich growth medium, a low signal to standard growth medium.
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CHAPTER 6
Dynamic control of small
molecule concentration in a
microfludics device
In this Chapter, I describe the implementation of an active control strat-
egy for regulating tetracycline concentration (or any other small molecule)
within a microfluidic device. First, I identify a dynamical model describ-
ing the accumulation of tetracycline in the microfluidic device by using the
experimental platform presented in Chapter 3. I then designed and imple-
mented a Model Predictive Control strategy in order to regulate tetracycline
concentration in the microfluidic device using as actuators two motorized sy-
ringes. Part of this work has been published in [63].
6.1 Motivation
The technological platform described in Chapter 3 allows to manipulate and
observe mammalian cells in real-time thanks to a microfludics device with
33 cell chambers all connected to the same main channel that continuously
delivers growth medium to the cells in the chambers (refer to Figure 3-2 in
Chapter 3). Since the cell chambers are connected to the main channel by
micro-channels perpendicular to it, cells are not subjected to a direct flow,
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but rather the medium in the chambers is exchanged by diffusion. This
prevents cell death due to mechanical shear stress on the cell membranes, at
the cost of a slower "refresh rate" of the chamber content.
The flow with the main channel is constant but the on-chip Dial-A-Wave
(DAW) hydrostatic pressure generator can be used to vary in real-time the
concentration of a molecule of interest (e.g. tetracycline) within the main
channel. Specifically the DAW consists of a set of microfludics channels
connected to the main channel that allows to mix the content of two liquids
in two syringes connected to two inlets by changing the relative height of
the two syringes (refer to Figure 3-3 in Chapter 3). Specifically, if one
syringe contains growth medium and the other the same growth medium
but also a given concentration of a small molecule (e.g. tetracycline), it is
then possible to modulate the concentration of compounds within the main
channel (Figure 6-1 A,B).
In order to automate the platform, two vertically mounted linear actu-
ators connected to the two syringes were designed and built to move in-
dependently. The motion is achieved through a stepper motor while the
transmission by using a timing belt and two pulleys (for each of the rail).
The actuator design is presented in Figure 6-2. The syringes used in this
design, have no plunger, since these are used simply as tanks to store the
media. The details on the sizing of the stepper motors are presented in
[21, 50].
From the experimental point of view, however, what is necessary is to
be able to dynamically change the concentration of the small molecule in
the cell chambers according to a desired reference, and not in the main
channel. Since the main channel is connected to the chambers by micro-
channels perperdicular to it, diffusion phenomena from the main channel to
the cell chamber must be taken into account in order to effectively control
the concentration of the small molecule reaching the cells.
For these reasons, the technological platform presented in Chapter 3 was
modified by including an active control of tetracycline concentration in the
cell chambers.
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Figure 6-1: Actuation system and hydrostatic pressure effect in the
DAW junction in the microfluidic device. (A) Syringes are constrained
to slide on pulleys. Regulating the stepper motors, each syringe is allowed
to reach a desired height between the lowest 0 and the highest hmax. h1
represents the height of the tetracycline filled syringe and h2 is the height of
the syringe with standard medium. The heights are taken at free surface of
the medium. (B) For ∆h = h1−h2 = m the tetracycline-medium/standard-
medium mixing ratio is equal to 0%, meaning that only standard medium
is given to the cells. For the dual situation (∆h = M with M = −m) the
mixing ratio is equal to 100% and tetracycline at its maximum concentration
flows to the cells. When the two syringes are at the same level the mixing
ratio is equal to 50%, thus the cells are fed with 50% of maximum tetracycline
concentration.
The modeling and the control of the tetracycline concentration in the
microfludics cell chambers will be the topics of the next sections.
6.2 Modeling tetracycline accumulation in cell
chambers
The identification of the parameters of mathematical model able to capture
the dynamics of the tetracycline accumulation in cells chambers has been
carried out without assuming any a priori knowledge of the tetracycline flow
in the microfluidic device. Input and output data have been used to fit the
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Figure 6-2: Motorised linear rails. In this picture the two designed linear
rails are presented. The external frame sustains the holder for the stepper
motor and the two pulleys on which the timing belt is meant to slide. The
sliding element is mechanically secured to the belt in order to allow coherent
movements.
model structure, thus considering the system as a "black box" [34].
The strategy I followed is to dynamically modulate the differential heights
between the two syringes, as input to the system, and to follow the dynamics
of the tetracycline accumulation in the cells chambers in response to such
an input (Figure 6-3).
The concentration of tetracycline is tracked by adding a red fluorescent
dye (Sulforhodamine) to the tetracycline-filled syringe and the medium flu-
orescence in the microfluidic chambers is imaged by a time lapse microscope
at regular sampling time. Therefore it is possible to obtain a time profile
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Figure 6-3: Technological platform. The relative heights between the
two syringes (filled with or without tetracycline) changes, thereby varying
the tetracycline concentration in the microfluidic device. A fluorescent dye
is added to the syringe with tetracycline. The dye fluorescence is imaged by
a time lapse microscope and it is quantified to follow the dynamics of the
tetracycline accumulation in the cells chambers in response to the variation
of the differential heights of the automated syringes.
of the actual tetracycline concentration flowing in the microfluidic chambers
by measuring the fluorescence of the medium in the red spectrum. The level
of red fluorescence is considered as the output of the system.
For the sake of clarity, in this discussion the input signal is normalized
between 0 and 1 as shown in Figure 6-1. Thus, if we call h1 and h2 the
current height of the syringe with tetracycline and with standard medium,
respectively, we have
h¯1 =
h−hmin
hmax−hmin ,
h¯2 = 1− h¯1
(6-1)
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Figure 6-4: Experimental data. (A) The red signal is the fluorescence
of tetracycline rich medium measured during the identification experiment.
This signal is considered the output of the system. (B) The input of the sys-
tem (black line) is represented by the relative height between the syringes
on the linear rail. h¯1 is the height of the tetracycline-filled syringe, here nor-
malized between 0 and 1. The height of the syringe with standard medium
is h¯2 = 1− h¯1.
where hmin is the lowest height that a syringe can reach on the rail, hmax is
the highest, h¯1 and h¯2 are the normalized heights.
Experimental data. The fluorescence of the tetracycline rich medium
in the microfluidic chambers is captured every minute for up to 350 minutes
(Figure 6-4 A). During this time, the relative height between the two sy-
ringes is varied according to the a triangular wave with several frequencies
(Figure 6-4 B).
The representative data set shown in Figure 6-4 is consistent with the
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expected behaviour of the DAW channel in the microfluidic device. Indeed
when the syringe with tetracycline rich medium is in its high position on the
rail (h¯1 = 1), the maximum level of tetracycline concentration flows in the
microfluidic chambers. Viceversa when this syringe occupies the lowest posi-
tion respect to the syringe with standard medium (h¯1 = 0), the tetracycline
is absent in the cells chambers. Finally, by changing the respective position
between the two syringes on the linear rail, any tetracycline concentration
can flow in the microfluidic device.
Black box identification. State space model. I have used the
technological platform depicted in Figure 6-3 and the experimental data
shown in Figure 6-4 to identify the following one dimensional state space
model describing the accumulation of tetracycline in the microfluidic device:
x˙ = ax+ bu, x(0) = x0, u ∈ [0, 1]
y = cx
(6-2)
In the model 6-2, x is the system state, u is the system input (the relative
height of the syringes on the linear rail), yk is the system output (tetracycline
accumulation in the microfluidic chambers) and x0 is the initial condition.
The system order n, the model parameters and the initial condition were
estimated from the data set in Figure 6-4 by applying the prediction error
minimization algorithm (PEM, [34]).
The estimated model coefficients and the initial condition are:
a = −0.2234, (6-3)
b = 0.0506, (6-4)
c = 4.9643, (6-5)
x0 = 1.12 (6-6)
The model was able to predict the experimental data across the identification
scenario, as depicted in Figure 6-5. Observe that according to parameter a,
the settling time for tetracycline within the cell chamber is of the order of
20 minutes.
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Figure 6-5: Fitting. (A) The solid blue line represents the simulated out-
put of the state space model identified with prediction error minimization
algorithm and the red dashed line is the fluorescence of the tetracycline rich
medium measured during the identification experiment (B) The input of the
system (black line) is represented by the relative height of the syringes on
the linear rail. This signal is used both to identify and to validate the model.
6.3 Dynamic control of small molecule concen-
tration in cell chambers with an Model Pre-
dictive Control strategy
Once I inferred a dynamical model of tetracycline accumulation in the mi-
crofluidic cell chambers, I aimed at synthesizing a negative feedback control
strategy to dynamically regulate the actual concentration of tetracycline in
the microfluidic cell chambers using the experimental platfrom depicted in
Figure 6-6.
77
desired
concentration
of tetracycline
electrical
input
any 
concentration
of tetracycline 
tetracycline
controller
image
processing
device
motorized
syringes
measured red
Figure 6-6: Negative feedback control of tetracycline concentration
in microfluidics cell chambers. The desired tetracycline concentration
is the reference signal. The red fluorescence is measured at regular sam-
pling time of 1 minute. The measured red fluorescence is compared to the
reference and a MPC strategy modulates the differential positions of the au-
tomated syringes on the linear rail in order to have a the desired tetracycline
concentration reaching the cells chambers in the microfluidic device.
The control input is a train of DC voltage pulses delivered to the two
stepper motors guiding the two syringes on the linear rail in order to change
their differential height and hence the concentration of tetracycline reach-
ing the cells chambers via the Dial-a-Wave (DAW) mixing channel in the
microfluidic device (see Figures 6-1 and 6-6).
6.3.1 Model Predictive Control
In order to design the controller, I decided to implement a Model Predictive
Control (MPC). The choice of the MPC was dictated by the constrain in
the control input which is bounded, since the rails where the syringes are
positioned has finite length. In the following, the relative height if the two
syringes is normalized between 0 and 1 as shown in Figure 6-1.
As described in Chapter 2, the MPC is an optimization based strategy
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that predicts the future evolution of the process under investigation and
optimizes the control input by minimizing at each sampling time a function
of the control error over a finite future horizon.
In order to predict the future response of the controlled plant, I used
the following discretised version of the tetracycline accumulation model in
Equation (6-2) obtained by applying the zero-order hold (ZOH) method
described in [61]:
xk+1 = axk + buk, x(0) = x0 uk ∈ [0, 1]
yk = cxk
(6-7)
where a = 0.800, b = 0.045, c = 4.9643 and x0 = 1.12.
In the MPC implemented for the regulation of tetracycline, the cost
function to be minimizes is the Sum of the Squared control Error (SSE),
defined as
SSEk =
k+N∑
i= k+1
(
N + 1 + k − i) 2i
=
k+N∑
i= k+1
(
N + 1 + k − i) (ri − yi)2
(6-8)
where the integer N defines the length of the prediction horizon in terms of
sampling intervals (set as N = 15, corresponding to 15 minutes) and yi is
the output of the dynamical model describing the tetracycline accumulation
in the cells chambers.
Therefore, at each sampling time kT the MPC algorithm solves the fol-
lowing optimal control problem over the prediction horizon of N steps start-
ing from the current system state x(KT ) :
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min
{uk+1,...,uk+N}∈[0,1]
SSEk
s.t.
xi+1 = axi + bui
yi = Cxi
xk is given
yi ∈ [0, 1]
i ∈ {k + 1, . . . , k +N}
(6-9)
The optimization is carried out with fmincon routine of the MATLAB Sys-
tem Idenfication toolbox (Mathworks Matlab R2016b). This function solves
linear least squares problem with non negative variables using the active-set
algorithm described in [64]. The result of the optimization is an array of N
optimal control inputs. The feedback loop is closed by applying only the first
element of the calculated array of control inputs and at the next sampling
time the entire procedure is repeated.
6.3.2 Experimental validation of the MPC strategy.
To perform the control experiments, I integrated the described control law
into the experimental platform shown in Figure 6-6. I then filled one sy-
ringe with standard growth medium and one syringe with standard growth
medium plus tetracycline at a concentration of 100ng/µl and sulforhodamine,
a non toxic fluorescent dye emitting in the red spectrum, at concentration
of 1µM in order to quantify tetracycline concentration via fluorescence mi-
croscopy.
At each sampling time (T = 1 min), an image is acquired by the micro-
scope and the normalized red fluorescence in the microfluidic chambers is
quantified. The actual concentration of tetracycline, which is proportional
to the level of the red fluorescence in the microfluidic chambers, is compared
to the reference. The control input is then computed by using the imple-
mentation of the MPC discussed in 6.3.1 thus determining the heights of the
syringes on the linear rail through the stepper motors.
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The control task consists in signal tracking of an descending staircase.
The reference r is a descending staircase of 3 steps where each step has a
duration of 50 min and an amplitude, respectively, of a 75%, 50% and 25%
of the maximal red fluorescence (here normalized to 1) measured during a
calibration phase of 10 min.
The results of the control experiments are reported in Figure 6-7.
It can be appreciated in Figure 6-7 that MPC strategy described in 6.3.1
is not able to bring the tetracycline level (red line, y) to the desired value
(reference, r ) and a non zero control error is present over the entire control
experiment. I found that this offset is due to the autofluorescence of the
growth medium. Indeed, even in the absence of red fluorescent dye, the
standard medium without tetracycline has an intrinsic fluorescence (named
autofluorescence). However, this autofluorescence can be considered as a
constant disturbance on the output and thus I moved to develop an offset-
free Model Predictive Control as described in [65] in order to ensure a zero
control error at steady state.
6.4 Dynamic control of small molecule concen-
tration in cell chambers with an Offset-
Free Model Predictive Control strategy
In order to remove offset, in [65] the authors design a control system that
can remove asymptotically constant, nonzero disturbances on the output.
To this end, the original dynamical model of the process being controlled
is augmented with an additional state representing the unknown constant
disturbance dk.
Thus the discrete model (6-7) describing the accumulation of tetracycline
in the microfluidic chambers, is augmented as follows:[
xk+1
dk+1
]
=
[
a 0
0 1
] [
xk
dk
]
+
[
b
0
]
uk,
[
x(0)
d(0)
]
=
[
x0
d0
]
, uk ∈ [0, 1]
yk =
[
c 1
] [xk
dk
] (6-10)
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Figure 6-7: Experimental results following MPC of tetracycline con-
centration in the microfludics device. (A) The control experiment
starts at time t = 0 and lasts for 150 minutes. The reference r in blue is
a step-like signal. Each step is calculated as a percentage (75%, 50% and
25%) of the fluorescence intensity quantified during the calibration phase of
10 minutes at the beginning of the experiment, here normalized to 1. The
red line is the measured fluorescence signal (model output, y). (B) The con-
trol input is the black line and represents the relative height between the
tetracycline-filled syringe and standard medium-filled syringe on the rail. h¯1
is the height of the tetracycline-filled syringe, here normalized between 0
and 1. The height of the syringe with standard medium is h¯2 = 1− h¯1.
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I then designed a Kalman filter as described in Section 2.4 in order to
estimate the state xk, and the disturbance dk, given the output yk.
In order to validate the Offset-Free Model Predictive Control strategy, I
first validated the Offset-Free Model Predictive Control strategy described
above by simulating the tetracycline accumulation in the microfluidic cham-
ber using the dynamical model (6-2).
The control task was to follow two difference references r: (i) a step-
like signal where each step lasts 100 minutes and is set equal to 75%, 50%
and 25% of the initial red fluorescence value (Figure 6-8) and (ii) a linear
descending ramp of 150 minutes starting at the 100% of initial fluorescence
and decreasing down to 25% (Figure 6-9).
As I already described in section 6.3.2, tetracycline is tracked by adding
a red fluorescent dye to the tetracycline-filled syringe, thus the value of the
average fluorescence in the microfluidic chamber is the measured output of
the system and it is proportional to the tetracycline concentration.
In the simulated experiments (Figures 6-8 A and 6-9 A), the initial value
of the red fluorescence is calculated as the steady state of the output of model
in the absence of tetracycline (6-2). The numerical simulations indicate that
Offset-Free MPC strategy is able to steer tetracycline concentration to the
desired value.
Therefore, I decided to perform the same control tasks experimentally.
The results of experiments are shown in Figures 6-8 B and 6-9 B. At the
beginning of each experiment, a calibration phase of 10 minutes is used to
quantify the maximum level of red fluorescence, which is then used to set
the unit of measure of the reference signal.
The experimental results confirm those obtained in simulations, as de-
picted also from the performance indices (Integral Square Error ISE, Integral
Absolute Error IAE, Integral Time Absolute Error ITAE) in the Figures 6-8
C and 6-9 C.
In conclusion the control strategy to regulate tetracycline concentration
in the microfluidic device presented in this Chapter allows to deliver any
time-varying concentration of tetracycline (or any other small molecule) to
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the cells growing in the cell chambers. This feature will be exploited in in
Chapter 7 to control gene expression from a tetracycline inducible promoter.
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Figure 6-8: Offset-free MPC staircase tracking control of tetracy-
cline accumulation. (A) in silico control experiment performed on the
tetracycline accumulation dynamical model. The reference (r in blue) is a
three steps signal where each step is calculating as a percentage (75%, 50%
and 25%) of the high steady state of the model’s output here normalized to
1. The green line is the model’s output (y). (B) in vitro control experiment.
The control action starts at time t = 0 min. The reference (r in blue) is
a percentage of the initial value of medium red fluorescence calculated in
the calibration phase. The red line is the measured red fluorescence (y).
(C) Performance indices calculated over the control time interval: Integral
Square Error (ISE), Integral Absolute Error (IAE), Integral Time Absolute
Error (ITAE).
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Figure 6-9: Offset-free MPC tracking control of tetracycline accu-
mulation. (A) in silico control experiment performed on the tetracycline
accumulation dynamical model. The reference signal (r in blue) a linear de-
scending ramp of 150 min. The green line is the model’s output (y). (B) in
vitro control experiment. The control action starts at time t = 0 min. The
desired level of fluorescence (r, in blue) is a linear descending ramp start-
ing at 100% of the initial value of medium fluorescence and going down to
25%. The red line is the measured red fluorescence (y). (C) Performance in-
dices calculated over the control time interval: Integral Square Error (ISE),
Integral Absolute Error (IAE), Integral Time Absolute Error (ITAE).
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CHAPTER 7
Model Predictive Control of Gene
Expression from the
tetO7 -UbV 76GFP Synthetic
Network with a Continuous
Control Input
In this Chapter, I describe the implementation of a control strategy equipped
with a continuous actuation by enabling any desired tetracycline concentra-
tion to be provided to the cells. To validate the implementation of this
control strategy, I first carry out numerical simulations and I compare the
performance achieved by the controller with either discrete or continuous
actuation. Finally, I present preliminary experimental results of in vitro set
point control experiment using continuous actuation. Part of this work has
been published in [63].
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7.1 Derivation of the mathematical model for
tetO7 -UbV 76GFP network with continuous
input
The experimental results described in Chapters 4 and 5 convincingly demon-
strate that the expression of a protein can be controlled in vitro in real-time,
using an inducer molecule, by applying a discrete actuation signal, i.e. ei-
ther standard medium or medium with tetracycline at concentration of 100
ng/ml can be provided to the cells.
However, it is important to note that for the biological models in exam
the concentration of tetracycline to be supplied to the cells could be graded,
obtaining thus a continuous control input which may lead to improved con-
trol performances. This would require a highly refined calibration of the
actuator that can be avoided by introducing in the experimental platform
the tetracycline concentration controller implemented in the Chapter 6 .
As a testbed for the controller equipped with a continuous actuation,
I chose to control the tetO7 -UbV 76GFP system described in Chapter 5. In
this system, the tetracycline Transactivator (tTa) protein is expressed from a
constitutive CMV promoter and it drives the expression of the destabilised
reporter protein UbV 76GFP from the inducible CMVTET promoter on a
separate transcriptional unit. If tetracycline is added to the culture medium,
it binds to tTa blocking its activity and thus the expression of UbV 76GFP
protein. The tetO7 -UbV 76GFP system can be viewed as a single input-
single output (SISO) dynamical system. The input u(t) is the concentration
of tetracycline in the growth medium and the output y(t) is the level of the
UbV 76GFP fluorescence across the cell population.
This system can be described by the UbV 76GFP.DI model in Equation
(5-4) inferred in the Chapter 5, but the effect of inducer molecule (tetracy-
cline) on the tetO7 -UbV 76GFP system is now modelled by the Hill function
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[15], thus obtaining the following dynamical model:
dx1
dt
= −d1x1 + β1
(
kn
kn + un
+ γ
)
u ∈ [0, 1]
dx2
dt
= α2x1 − d2x2
dx3
dt
= α3x2 − d3x3
(7-1)
where x1 is the concentration of UbV 76GFP mRNA, x2 and x3 are the con-
centrations of UbV 76GFP unfolded protein and UbV 76GFP folded protein,
respectively. β1, α1 and α2 represent the production rates and d1, d2 and
d3 are the degradation rates. u represents the tetracycline concentration
while the system output (i.e. the measured fluorescence of the functional
UbV 76GFP protein) is x3.
In order to obtain the model parameters, I performed two steps identifica-
tion: (i) first I identified the coefficients of the Hill function g(u) = kn
kn+un
+γ
and (ii) then the other model parameters were identified by using a grey-box
identification approach from experimental data.
For identifying the Hill function coefficients, I took advantage of the
tetracycline control platform discussed in the Chapter 6 to perform an auto-
matic dose-response experiment (Figure 7-1) by measuring cells fluorescence
in response to tTa protein at several concentrations of tetracycline. In order
to track tetracycline presence in the cell chambers, a fluorescent dye (Sul-
forhodamine) is added to the tetracycline rich medium. Cells’ fluorescence
is imaged at 15 minutes intervals by the time lapse microscope and it is
quantified by image segmentation algorithm in Appendix A (Figure 7-1 A).
I assumed that at each tetracycline concentration the value of fluorescence
reaches the steady state level at the end of the step (Figure 7-1 B) and the
coefficients of the Hill function were fitted to these experimental data, as
shown in the Figure 7-2.
In order to identify the other model parameters, I performed a grey-box
identification by using nlgreyest function from MATLAB System Idenfica-
tion toolbox (Mathworks Matlab R2016b) from the input-output data in
Figure 7-3 obtained as discussed in the section 5.2. I named the identified
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Figure 7-1: Automatic microfluidic-based dose-response experi-
ment. The variation of cells fluorescence in response to several tetracy-
cline concentrations. (A) The average fluorescence across cell population is
measured at 15 minutes intervals (green line).(B) Several concentration of
tetracycline are given to the cells by means of the motorized syringes. The
controller of tetracycline accumulation in microfluidic device ensures that
the actual tetracycline concentration in the microfluidic device (red line) is
equal to the desired value (blue signal).
model in Equations (7-1) UbV 76GFP.CI model where CI stands for Contin-
uous Input.
A list of all model parameters and the performance indices AIC, FPE
and FIT%, defined in Chapter 5, are reported in Tables 7-1 and 7-2.
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Figure 7-2: Hill function describing the effect of tetracycline on the
CMVTET promoter. Numerical fitting of the dose response curve of the
CMVTET promoter to several concentration of tetracycline. The green dots
are the experimental data and the black line is the numerical fitting of the
HIll function to the data.
Table 7-1: Model parameters
Parameter Description Value
d1 [min
−1] degradation rate of UbV 76GFP mRNA 0.0098
d2 [min
−1] degradation rate of UbV 76GFP unfolded protein 0.0199
d3 [min
−1] degradation rate of UbV 76GFP folded protein 0.0204
α2 [min
−1] production rate of UbV 76GFP unfolded protein 0.0139
α3 [min
−1] folding rate of UbV 76GFP protein 0.0172
β1 [min
−1] CMVTET maximum transcriptional rate 0.0117
γ [a.u.] CMVTET leakiness 0.011
k [a.u.] Tetracycline concentration to achieve β1
2
0.62
n Hill coefficient 3.45
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Figure 7-3: Identification experiment. (A) The solid blue line is the out-
put of the state space model identified with nlgreyest function from MAT-
LAB System Idenfication toolbox (Mathworks Matlab R2016b). The green
dashed line is the average cell fluorescence measured during the experiment.
(B) The input (red line) is the tetracycline pulses. This signal is used both
to identify and validate the obtained model. The red signal is the fluores-
cence of the dye added to the tetracycline rich medium measured during the
experiment.
Table 7-2: Values of the performance indices for UbV 76GFP.CI model.
FPE 5.58 ∗ 10−3
AIC −5.1890
FIT 62.3%
7.2 Controlling tetO7 -UbV 76GFP gene expres-
sion with a continuous control input
In order to implement a control strategy to steer expression of the UbV 76GFP
with a continuous control input, I took advantage of the integrated exper-
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imental platform described in Chapter 3. However, in the original control
scheme, a discrete control input was used, that is only tetracycline rich
medium or standard medium was provided to the cells. In order to move
from a discrete (binary) control input to a continuous control input, I needed
to finely control the action of the actuators (motorized syringes) and con-
sequently the tetracycline concentration in the microfluidic device. I thus
modified the technological platform as shown in Figure 7-4 to include an
active control of tetracycline concentration in the microfluidic cell chambers.
As Figure 7-4 shows, the original platform is endowed with an inner
loop (tetracycline concentration control loop) in which the measured level
of tetracycline (u) is compared to the desired tetracycline concentration
(ud), i.e. the continuous control input computed by the gene expression
controller. The tetracycline controller modulates the relative height of the
syringes on the linear rails in order to provide cells with the desired amount
of tetracycline. More details on the tetracycline concentration controller are
reported in Chapter 6.
7.2.1 Control objective and controller design
The control tasks were either set point regulation or signal tracking. In
the set point regulation, the reference value r(t) is calculated as the 50%
of the initial average fluorescence expressed by the cells in the calibration
phase of 180 minutes at the beginning of the experiments. In the signal
tracking contro,l I used two different references r: a sinusoidal wave of period
T = 3000 min defined as s = 0.5+0.25∗sin(2 pi
T
(t−100)+ pi
2
) and a staircase
function beginning at 50% of initial average fluorescence, then going to 25%
and then 75%.
As the system output y(t) I considered the average level of fluorescence
in the cell population in order to reduce the noise measurements due to the
cell-to-cell variability in the protein production.
The results achieved controlling gene expression by using a model predic-
tive control with a discrete control input, as detailed in Chapter 5, convinced
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Figure 7-4: Technological control platform for continuous control in-
put. The experimental platform described in Figure 4-3 is endowed with a
tetracycline controller that makes the actual concentration of input molecule
(u) equal to the desired concentration (ud) computed by the gene expres-
sion controller. The concentration of tetracycline in the growth medium
is quantified by the addition of a fluorescent dye to the syringe containing
tetracycline and it is imaged by the microscope at regular sampling time
and converted to a quantitative value via an image processing algorithm.
me to implement an MPC based strategy also when regulating gene expres-
sion with a continuous control input.
As already discussed in the Chapter 2, the Model Predictive Control
(MPC) algorithm is an iterative optimization-based strategy that, at each
sampling time kT, uses mathematical model of the plant to predict the
future value of a cost function over a finite time prediction horizon. The
MPC strategy then calculates the optimal control input over the prediction
horizon that minimizes the cost function.
I implemented the MPC strategy using a discretised version of theUbV 76GFP.CI
model in Equation 7-1. Since the considered dynamical model is non linear
in the input, I first performed an input transformation and then applied the
zero-order hold method to convert the continuous model to a discrete one,
as described in [61], thus obtaining the following discrete linear model:
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xk+1 = Axk + Buk, uk ∈ [0, 1] x(0) = x0
yk = Cxk
(7-2)
where xk =
x1(kT )x2(kT )
x3(kT )
 are the system states, uk = u(kT ) is the input
and yk = y(kT ) is the system output. The matrices A, B and C are:
A =
a11 0 0a2,1 a2,2 0
a3,1 a3,2 a3,3
 (7-3)
B =
b1b2
b3
 (7-4)
C =
(
0 0 c3
)
(7-5)
According to the model in Equation (7-2), at each sampling instants kT ,
starting from the current state information x(kT ) the MPC solves the fol-
lowing open loop optimal control problem over the prediction horizon N
min
{uk+1,...,uk+N}∈[0,1]
SSEk
s.t.
xi+1 = Axi + Bui
yi = Cxi
xk is given
yi ∈ [0, 1]
i ∈ {k + 1, . . . , k +N}
(7-6)
where the cost function SSEk is the sum of the squared control error (SSE)
defined in Equation (5-14). The state system are reconstructed using the
Kalman filter described in Chapter 2. The optimization is carried out by
using the Matlab implementation of the fmincon function that solves opti-
mization problem with the active-setalgorithm described in [64]. The result
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of the optimization is an array of N optimal control inputs (ui). The opti-
mal control input is used to decide the concentration of tetracycline to be
provide to the cells. In principle in absence of external disturbances the
optimal input could be applied over the entire prediction horizon. However
in order to make the control action robust to any source of uncertainty and
variability, the feedback loop is closed by applying the calculated control
input only at the current sampling time and at the successive sampling time
the entire procedure is repeated.
7.3 Numerical simulations and comparative anal-
ysis of the MPC strategy with either dis-
crete or continuous control input for gene
expression control regulation
7.3.1 Numerical validation
I numerically tested the control strategy with the continuous actuation
by simulating the whole experimental setup consisting of both the tetra-
cycline concentration controller (for more details see Chapter 6) and the
model predictive controller of gene expression with continuous control in-
put as described in the section 7.3.1. In the numerical simulations, in the
place of the living cells integrating the tetO7 -UbV 76GFP system, I used
the UbV 76GFP.CI model in Equation (7-1) to simulate UbV 76GFP protein
expression. In order to simulate tetracycline accumulation in the cell cham-
ber, I used the model described by the Equations 6-2, which I obtained as
described in Chapter 6.
With continuous control input, cell can be provided with any interme-
diate concentration of tetracycline, thanks to the presence of the additional
tetracycline controller ensuring that the desired tetracycline concentration
calculated by the gene expression controller is indeed provided to the cells.
With discrete control input, cells are provided with only two levels of tetra-
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cycline, either the maximum concentration or no tetracycline is provided to
the cells, as shown in detail in Chapter 5.
The controllers were simulated to perform both set-point regulation and
signal-tracking of the model output.
As already described in Chapter 5, the MPC with discrete control input
when applied to set point control (Figure 7-5 A), is able to force the model’s
output (y) to reach the control reference (r) and to maintain its value over
time without exhibiting any oscillation. Comparing this result with the
performance achieved by the MPC with continuous control input (Figure 7-
5 B), the performance indices (ISE, IAE, ITAE in Figure 7-5 C) calculated
considering the steady state error (over the last 3000 minutes of simulations)
are of several orders of magnitude better in the continuous control input
MPC strategy. Thus the gene expression control in mammalian cells is
improved when using a continuous actuation based control strategy.
In the case of signal tracking control (Figure 7-6 and Figure 7-7) the
performance of the MPC with discrete control input is worst than that with
the continuous actuation as confirmed by the performance indices.
Interestingly the continuous control input MPC strategy is able to achieve
an optimal performance with a very small variations of tetracycline concen-
tration. Furthermore from a biological point of view, slower is the variation
in the tetracycline concentration (variation of control input), lower is the
stress occurring to the cells.
7.3.2 In vitro experiments: preliminary results
The results obtained by the numerical analysis show that the MPC based
control strategy with continuous control input is feasible and advantageous
over the MPC with discrete control input.
In order to verify whether the outcome of the numerical simulations
can be confirmed experimentally controlling living cells using microfluidics,
tetO7 -UbV 76GFP cells were loaded in the microfluidic device and allowed
to grow for 24 hours under perfusion conditions in a cell culture incuba-
tor. Then the device was moved to the inverted microscope, and the images
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acquisitions and the control experiment were started (the experimental pro-
tocol is reported in APPENDIX).
The control task consisted in reaching and maintaining 50% of the initial
value of UbV 76GFP fluorescence calculated as the mean value of fluorescence
over the calibration phase at the beginning of the control experiment.
In this phase, lasting 180 minutes, the cells are kept in medium without
tetracycline, thus the UbV 76GFP protein is switched on and its fluorescence
is quantified in order to calculate the reference value. The control action
starts at time t = 0 minutes and finishes at t = 1000 minutes. As shown
in Figure 7-8, the control action works effectively in keeping the output,
namely the measured fluorescence, close to the desired set-point for 500
minutes. However in the both experiments, around the 650 minutes the
cells fluorescence increases even if high concentration of tetracycline is given
to the cells (the control input is high, red signal in the Figure 7-8). This
drawback is due to the fact that during these experiments some technical
problems linked to cell death and the algorithm of segmentation failure have
occurred. Indeed when cells die, they incorporate red dye that interferes in
the quantification of the green fluorescence by means of the segmentation
algorithm.
Nevertheless these preliminary results represents a good starting point
to demonstrate that the implemented control strategy with a continuous
actuation is suitable to regulate at will a protein of interest. Moreover the
opportunity to slowly change the levels of the inducer molecule (control
input) allows to reduce the stress filled by the cells.
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Figure 7-5: Numerical simulations of tetO7 -UbV 76GFP set point
control. (A-B) Two numerical simulations of set point control were per-
formed on the tetO7 -UbV 76GFP dynamical model by means of either the
MPC with discrete control input (A) or the MPC with continuous control
input (B). The reference signal, r in blue, is equal 50% of the steady state
of the model’s output for a null concentration of tetracycline in input, here
normalized to 1. The green line is the model’s output (y) and the red line
represents the control input (u). The black line in the MPC regulation with
a continuous control input (B) is the desired control input (ud) computed
by the gene expression controller. (C) Performance indices: Integral Square
Error (ISE), Integral Absolute Error (IAE), Integral Time Absolute Error
(ITAE).
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Figure 7-6: Numerical simulations of tetO7 -UbV 76GFP signal track-
ing control. (A-B) Two numerical simulations of cosine wave tracking con-
trol experiments performed on the tetO7 -UbV 76GFP dynamical model by
means of either the MPC with discrete control input (A) or the MPC with
continuous control input (B). The reference signal (r in blue) is a steady
state signal equal to 75% of the steady state of the model’s output for a null
concentration of tetracycline in input, here normalized to 1 with a duration
of 500 min followed by a sinusoidal wave of period T = 3000 min defined as
s = 0.5+0.25∗sin(2 pi
T
(t−100)+ pi
2
). The green line is the model’s output (y)
and the red line represents the control input (u). The black line in the MPC
regulation with a continuous control input (B) is the desired control input
(ud) computed by the gene expression controller. (C) Performance indices:
Integral Square Error (ISE), Integral Absolute Error (IAE), Integral Time
Absolute Error (ITAE).
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Figure 7-7: Numerical simulations of tetO7 -UbV 76GFP staircase
tracking control task. (A-B) Two numerical simulations of staircase
tracking control experiments performed on the tetO7 -UbV 76GFP dynami-
cal model by means of either the MPC with discrete control input (A) or
the MPC with continuous control input (B). The reference signal (r in blue)
is a three steps signal where each step is calculating as a percentage (50%,
25% and 75%) of the high steady state of the model’s output, here normal-
ized to 1. The green line is the model’s output (y) during the control time
interval and the red line represents the simulated control input (u). The
black line is the desired control input (ud) computed by the gene expression
controller. (C) Performance indices calculated over the control time interval:
Integral Square Error (ISE), Integral Absolute Error (IAE), Integral Time
Absolute Error (ITAE).
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Figure 7-8: In vitro tetO7 -UbV 76GFP set point control. (A-B) Two in
vitro set point control experiments performed on the TetO7 -UbV 76GFP sys-
tem by means of the MPC with continuous control input. The control action
starts at time t = 0 min. The reference signal (r in blue) is equal to 50% of
the initial value of UbV 76GFP fluorescence calculated as the mean value over
180 minutes prior to starting of control action (calibration phase). The green
line is the measured UbV 76GFP fluorescence (ym). The tetracycline concen-
tration is quantified by adding a fluorescent red dye in the tetracycline-filled
syringe, therefore the control input is the measured red fluorescence (red
signal, um) while the black line is the desired control input ud computed
by the gene expression controller. (C) Performance indices: Integral Square
Error (ISE), Integral Absolute Error (IAE), Integral Time Absolute Error
(ITAE).
CHAPTER 8
Conclusions
In this Thesis, I proposed a microfluidics-based feedback control strategy
to quantitatively regulate gene expression from a tetracycline-inducible pro-
moter in mammalian cells. The strategy proposed is based on the regulation
of gene expression by means of an inducer molecule (i.e. tetracycline), which
is able to block the transactivational activity of a constitutively expressed
transcription factor.
In Chapter 4, I presented a proof-of-principle study to demonstrate that
microfluidics-based control of gene expression in mammalian cells is feasible.
In order to do that, I chose two simple control strategies that do not require a
detailed quantitative model of gene expression (relay and PI). I showed that
it is indeed possible to force a population of cells harboring the inducible
promoter to express a predetermined level of a protein of interest by auto-
matically administering to the cells pulses of tetracycline whose duration is
computed in real time by the Relay and PI control algorithms. Oscillations
around the set point are to be expected when using these controllers. For ex-
ample, the relay control algorithm checks at each sampling time whether the
fluorescence has reached the desired value, and if it has not, then the algo-
rithm treats the cells with either tetracycline (to reduce the fluorescence) or
standard medium (to increase the fluorescence) for the whole duration of the
next sampling interval. This may cause fluorescence to decrease/increase too
much, so that at the next sampling interval its value will be below/above
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the desired level, giving rise to oscillations around the set point. Oscilla-
tions around the set point are well-documented in the control literature, for
example in the application of "bang-bang" control [66, 67]. This is an opti-
mal control strategy to minimize the time required for a physical system to
achieve the desired set point.
Despite the oscillations around the set-point value, the in vitro experi-
ments showed in Chapter 4 demonstrated that it is possible to regulate the
expression of a reporter protein from the tetracycline-inducible promoter in
a population of mammalian cells using principles from automatic control
engineering. This study, published in [51], was the first in which automated
control of gene expression from an inducible promoter has been achieved in
mammalian cells.
However, the control performance can be greatly improved by moving to
a model-based control strategy such as Model Predictive Control.
In Chapter 5 I presented a Model Predictive Control strategy to regulate
the gene expression with a discrete control input. Specifically the controller
automatically computed the length of pulses of tetracycline to give to cells.
I experimentally demonstrated how it is possible to eliminate oscillations
around the set-point by applying a model based control strategy thanks to
its predictive nature.
The experimental results described in Chapters 4 and 5 convincingly
demonstrated that the expression of a protein can be controlled in vitro in
real-time, using an inducer molecule, by applying a discrete actuation signal,
i.e. either standard medium or medium with tetracycline at predetermined
concentration be provided to the cells. However, for the biological models
in exam, the concentration of tetracycline to be supplied to the cells could
be graded, obtaining thus a continuous control input which may lead to im-
proved control performances. For this reason, in Chapter 6, I described the
implementation of an active control strategy to precisely regulate tetracy-
cline concentration in the microfluidic device. This strategy allows to deliver
any time-varying concentration of tetracycline to the cells growing in the cell
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chambers. This feature is then exploited in Chapter 7 to control gene ex-
pression from a tetracycline inducible promoter using continuous actuation.
As discussed in Chapter 2, the exploitation of Control Theory in bio-
logical systems began only recently, and with limited applications only in
lesser eukaryotes. In this work, I have generated preliminary results that
demonstrate that control gene expression in mammalian cells is possible.
The ability to set a desired level of protein inside cells, even at a constant
rate, will allow biologists to perform dose-response analyses that will pro-
vide a plethora of new quantitative data: activation thresholds, enzymatic
kinetics, protein aggregation studies and so on. This will be of paramount
interest to enrich our knowledge of basic biological processes, which is still
qualitative.
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APPENDIX A
Material and Methods
A.1 Cell culture
Chinese Hamster Ovary (CHO) cells (both tetO7 -d2EYFP and tetO7 -UbV 76GFP
cells) are cultured in αMEM (EuroClone) supplemented with 10% tetracycline-
free FBS (EuroClone), 1% Penicillin/Streptomycin (EuroClone), 2 mM Glu-
tamine (EuroClone) and 3µg/ml blasticidine (Sigma-Aldrich) and are kept
in a standard tissue culture incubator at 37◦C, 5% CO2, 98% of humidity.
Cells are splitted twice per week using PBS (Gibco) and trypsin (Gibco)
and seeded at 2000 cells/cm2.
The day before the loading of the microfluidic device cells were splitted
1:3 and placed back into the incubator.
A.2 Microfluidics
All the experiments presented in this study were performed by using the
microfluidic device for mammalian cells designed by Kolnik and colleagues in
the Jeff Hasty’s Bioengineering Laboratory at the University Of California,
San Diego [46]. This device allows to grow cells in temperature- and CO2-
controlled environment isolated from potentially damaging flow effects, to
administer in a precisely manner external input via a complex topology of
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channels connecting inlets between each other and the cells chambers (a
detailed description of its topology is in Chapter 3 and [46].
A.2.1 Device fabrication protocol
I have used replica molding technique to obtain polydimethylsiloxane (PDMS)
replicas of the device presented in [46] by using a master mold of the features
as blueprint. The master mold has been produced using a 4” silicon wafer
as substrate (Silicon Valley Microelectronics, US) by a way of layer-by-layer
photolithography [68].
Before the fabrication of the microfluidic devices the master is exposed to
chlorotrimethylsilane (Sigma-Aldrich Co.) vapours for 10 minutes in order to
create an anti-sticking silane layer for PDMS. PDMS is prepared by mixing
Sylgard 184 Elastomer curing agent and base (DOW corning) in a 1 : 10
ratio. PDMS is poured onto the master mold, degassed for 30 minutes,
cured for 1 hour at 80◦C, allowed to cool to room temperature and then
peeled from the wafer . PDMS was then autoclaved for 30 minutes at 121◦C
to ensure long-term viability of cells in the devices [69]. Holes for the 7 ports
were punched using a 24-gauge blunt needle in order to create fluidic ports
for the access of cells and liquid substances. The PDMS devices obtained
are rinsed in isopropyl alcohol and distilled water to remove debris. For each
PDMS piece containing microchannels a thin glass slide (150 µm) is cleaned
in methanol and 70% ethyl alcohol. Finally the PDMS layers and glass slides
are exposed to oxygen plasma in Plasma Cleaner machine (ZEPTO version
B, Diener electronic GmbH) for 2 minutes and brought into contact forms a
strong irreversible bond between two surfaces. As last step all devices were
checked for faults inside and outside the channels.
A.2.2 Device cells loading protocol
For device loading, cells are washed with sterile Phosphate-Buffered Saline
(PBS, Gibco), detached from the culture dishes by exposing to 0.25% Trypsin
EDTA for 1 minute and centrifuged to form a pellet. Then in order to obtain
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a seeding density of 3 − 5 cells per chamber, the cells pellet is resuspended
in complete media at a density of 0.064cells per mm2.
The channel of the device are then completely filled with fluid (except for
the culture chambers) by applying complete media first through port 5 and
then through port 2 once it is filled with fluid. The cell suspension is loaded
into the main channel of the device from port 2 and a vacuum is applied in
the channel adjacent to the culture chambers (ports 3 and 4) to evacuate
air and replace the chamber volume with fluid containing cells. Remaining
untrapped cells in the main channel are washed away at a high flow rate
without disturbing cells inside the traps. Fluidic connections from the ports
of the device to syringes containing growth medium are then established
using 24 gauge PTFE tubing (Cole-Parmer Inc.) interfaced via 22 gauge
stainless steel luer stub pins.
Once cells are loaded in the microfluidc device, they are allowed in a
cell culture incubator for 24 hours in perfusion conditions providing that the
cells in chambers receive fresh medium from syringe connected to port 5 and
the waste medium is washed trough port 1, while all the other ports (2,6
and 7) are plugged.
For both identification and control experiments, the device is secured
on the microscope stage within an environmental chamber maintained at
37◦C with humidified 5% CO2 and 60ml syringes are connected to its ports
and hanged at different heights, in order to regulate the flow from the in-
lets (ports 6 and 7) to the outlets (ports 5, 1 and 2) according to hydro-
static pressure. The syringes connected to the outlets port contain 10ml of
standard complete culture medium and they serve as a waste tanks. The
syringes connected to the inlets port are filled with standard medium and
medium with tetracycline at a concentration of 100ng/ml (Clontech) and
1µM Sulforhodamine 101 (Sigma) and secured on the linear actuator. The
correct functioning is checked by inspecting the red fluorescence emitted by
Sulforhodamine as a result of the automatic height control of syringes.
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A.2.3 Device loading protocol for the identification and
control of the dynamic of small molecule concen-
tration in cell chambers.
First the device is completely filled with small molecule filled fluid (except
for the culture chambers) by applying complete media first through port 5
and then through port 2 once it is filled with fluid. Then a vacuum is applied
in the channel adjacent to the culture chambers (ports 3 and 4) to evacuate
air and replace the chamber volume with fluid containing small molecule.
For both identification and control experiments, the device is the time
lapse and 60ml syringes are connected to its ports and hanged at different
heights, in order to regulate the flow from the inlets (ports 6 and 7) to the
outlets (ports 5, 1 and 2) according to hydrostatic pressure. The syringes
connected to the outlets port contain 10ml of standard complete culture
medium and are used as a waste tanks. The syringes connected to the inlets
port are filled with standard medium and medium with small molecule and
1µM Sulforhodamine 101 (Sigma) and secured on the linear actuator. The
correct functioning is checked by inspecting the red fluorescence emitted by
Sulforhodamine as a result of the automatic height control of syringes. the
fluorescence emitted by Sulforhodamine in cell chambers is used as a read
out in the identification and control experiments (see Chapter 6).
A.3 System identification experiment
A.3.1 TetO7 -UbV 76GFP system identification experi-
ment
Once TetO7 -UbV 76GFP cells loaded in the microfluidic device are put under
the microscope and the syringes are connected, they are kept in a standard
medium to allow cells adapt to the microchemostat environment simply by
holding the syringe filled with standard medium in a higher position respect
to the one carrying tetracycline rich medium. After this calibration phase
of the experiment, a sequential MATLAB script controls syringes’ positions
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over the time to obtain desired time profile for the input fed to cells. The
correct functioning can be check by inspecting the red fluorescence emitted
by Sulforhodamine in cells chamber.
The image processing algorithm, running in real time, calculates the
absolute fluorescence emitted by the entire cell population as well as its
normalised value by dividing the time course of fluoresce by the average flu-
orescence intensity measured during the initial calibration phase, obtaining
the output data.
Input and output time series thus generated are used, as discussed in
Section 5.2, to apply System Identification techniques.
A.3.2 Identification experiment for modelling tetracy-
cline accumulation in cell chambers
Once the microfluidic device filled with small molecule and Sulforhodamine is
under the microscope the small molecule filled syringe is keeping in higher po-
sition respect to the one carrying medium without the small molecule. After
this calibration phase of the experiment, a sequential MATLAB script con-
trols syringes’ positions and dynamically modulates the differential heights
between the two syringes over the time as system input.
The dynamics of the small molecule accumulation in the cells chambers
in response to such an input is followed by measuring red dye fluorescence.
The absolute fluorescence emitted by the Sulforhodamine in cells chambers
is calculated and it is normalised by dividing the time course of fluoresce
by the average fluorescence intensity measured during the initial calibration
phase, obtaining the output data.
Input and output time series thus generated are used, as discussed in
Section 6.2, to apply System Identification techniques.
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A.4 Control experiment
A.4.1 Gene expression control experiment
Both tetO7 -d2EYFP and tetO7 -UbV 76GFP cells control experiments are
carried out by using the same procedures.
Once microfluidic device with cells is secured on the microscope stage and
the syringes are connected, the user has to start a custom MATLAB script,
that manages the entire experimental platform (controller implementation,
actuation, image analysis), and has to set the duration (in minutes) of the
control, the crop area and the threshold needed for image analysis.
The script calculates the set point for the control as a percentage (in-
dicated by the user at the beginning of the experiment) of the average of
the fluorescence measured by the image processing algorithm during the
calibration phase previously described. After this the implemented script
proceeds in executing all the code blocks necessary to reach and maintain
the fluorescence reference.
A.4.2 Small molecule concentration control experiment
Also for the control of molecule concentration in the microfluidic device,
once the microfluidic is under the microscope a MATLAB script manages
the entire experimental platform. The duration of the control and the crop
area are setted at the beginning of the experiment. The script calculates the
length and the values of the steps in the step - like time varying reference
control and the value of reference in the tracking control as percentages (in-
dicated by the user at the beginning of the experiment) of the average of the
red fluorescence emitted by Sulforhodamine measured during the calibration
phase. In this phase the syringe with small molecule and Sulforodhamine
is higher than the other syringe. At the end of the calibration, the imple-
mented script proceeds in executing all the code blocks necessary to reach
and maintain the fluorescence reference.
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A.5 Fluorescence microscopy
The closed loop control platforms for gene expression control described in
the Chapter 3 and 7, employs an inverted fluorescence Nikon-TI Eclipse
microscope equipped with a digital camera (Andor iXon897, Andor) and an
incubation chamber (H201-OP R2, Okolab) to acquire images from cells in
the microfluidic device. To overcome the problem of the focus drift due to
cells growing and replicating and to the length of the experiments performed,
the microscope has been equipped with the Nikon Perfect Focus System
(PFS) that is able to compensate for axial focus fluctuations in real time
during long-term imaging experiments.
The microscope is programmed to acquire two types of images: a phase
contrast image (PhC) and a fluorescence image in green spectrum for the
fluorescent reporter used to track cell state and a fluorescence images in the
red spectrum for Sulforhodamine. Both PhC and fluorescence images are
acquired with the same objective (Obj. PlanFluor DLL 40X Ph2 Nikon,
NA 0.63) at intervals of 15 minutes. An automated shutter is used to finely
control the exposure times for each type of image acquired that are set to
286 ms for PhC image, to 300 ms for green spectrum with Nikon GFP BP
HYQ filter (Ex 490− 510 nm, Em 520− 550 nm) for UbV 76GFP and Nikon
FITC Filter (Ex 465− 495 nm, Em 515−555 nm) for the d2EYFP , to 300
ms for red spectrum, with a Nikon TRITC HYQ filter (Ex 530−560 nm, Em
590−650 nm). The exposure times and the acquisition interval of 15 minutes
have been chose to avoid phototoxicity damages to cells and photobleaching
of the fluorescent proteins/dyes [47]. Temperature is maintained constantly
at 37◦C, and CO2 concentration is set to 5% of the total air volume injected
in the incubation chamber.
For the small molecule concentration control the same microscope is
used. Since the Sulforhodamine is added to follow the dynamics of the
small molecule accumulation, the microscope is programmed to acquire a
fluorescence images in the red spectrum with Nikon TRITC HYQ filter (Ex
530 − 560 nm, Em 590 − 650 nm) at exposure times setted to 300ms. The
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images are acquired with the Nikon 40X dry objective, NA 0.63 at intervals
of 1 minutes.
A.6 Image analysis
Image Analysis, together with the microscope, composes the sensing appa-
ratus of the experimental platform. The outcome of the experiments shown
in this study is strictly dependent on the accuracy of the real time image
analysis performed. For this reason I used an image processing algorithm,
developed in the laboratory of Diego di Bernardo at TIGEM by Dr. Gi-
anfranco Fiore, that is meant to locate cells within each PhC frame, and
to use this information to calculate the fluorescence (corresponding to each
reporter or fluorophore) [50].
In this study I have considered Chinese Hamster Ovary (CHO) cells that
as other mammalian cells, do not have a particular geometrical shape [70],
the used image processing algorithm is not based on cells’ morphological
features but it exploits the property of cells to exhibit a white halo in Phase
contrast image, shown in Figure to locate the cells within image. Briefly,
the image analysis algorithm works as follow: (a) it defines a threshold to
generate a first binary image selecting only pixels belonging to cells’ edges
(Figure); (b) it obtains a second binary image (mask) in which the cell area
is overestimates by using dilation and filling operators; (c) by subtracting
from the mask obtained at point (b) that obtained at point (a), it derives
a binary image (Figure 8.2 C) that select the portion of the original image
covered by cells (Figure); (d) the binary filter obtained, is applied to green
field image to calculate the average intensity fluorescence of pixels belonging
to cells, subtracting the background signal.
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